Bibliography: library/10665-385385
The reference for library/10665-385385 (who-iris) and any references extracted from it. library · All references.
Export these 121 references: BibTeX · CSL-JSON · RIS · Dublin Core XML · Dublin Core / BIBO JSON-LD
✍ + Add reference (standalone node)
121 shown
-
World Health Organization (2026). Global hepatitis report 2026. World Health Organization.
10665-385385· catalogue · link · repository record · ISBN 9789240122383 (electronic version) · source:catalogue/records/10665-385385.dc.json· held:library/10665-385385
export: BibTeX · RIS · CSL-JSON · DC XML -
Resolution WHA63.18. Viral hepatitis. In: Sixty-third World Health Assembly, Geneva, 17–21 May 2010. Resolutions and decisions, annexes. Geneva: World Health Organization; 2010 (http://apps.who.int/gb/ebwha/pdf_files/WHA63-REC1/WHA63_REC1-en.pdf). Licence: CC BY-NC-SA 3.0 IGO.
· extracted · link · source:references/10665-385385.sec-007.1.jsonResolution WHA63.18. Viral hepatitis. In: Sixty-third World Health Assembly, Geneva, 17–21 May 2010. Resolutions and decisions, annexes. Geneva: World Health Organization; 2010 (http://apps.who.int/gb/ebwha/pdf_files/WHA63-REC1/WHA63_REC1-en.pdf). Licence: CC BY-NC-SA 3.0 IGO.
- Issued
- 2010
- Type
- document
- As printed
- Resolution WHA63.18. Viral hepatitis. In: Sixty-third World Health Assembly, Geneva, 17–21 May 2010. Resolutions and decisions, annexes. Geneva: World Health Organization; 2010 (http://apps.who.int/gb/ebwha/pdf_files/WHA63-REC1/WHA63_REC1-en.pdf). Licence: CC BY-NC-SA 3.0 IGO.
Sources
In the knowledge graph
- IRI
references/10665-385385.sec-007.1 - provenance: extracted
- read from
references/10665-385385.sec-007.1.json(who-iris, sub-graph who-iris-references) - derived from
library/10665-385385/sections/sec-007-references.md
-
Resolution WHA67.6. Hepatitis. In: Sixty-seventh World Health Assembly, Geneva, 19–24 May 2014. Resolutions and decisions, annexes. Geneva: World Health Organization; 2014 (http://apps.who.int/gb/ebwha/pdf_files/WHA67/A67_R6-en.pdf). Licence: CC BY-NC-SA 3.0 IGO.
· extracted · link · source:references/10665-385385.sec-007.2.jsonResolution WHA67.6. Hepatitis. In: Sixty-seventh World Health Assembly, Geneva, 19–24 May 2014. Resolutions and decisions, annexes. Geneva: World Health Organization; 2014 (http://apps.who.int/gb/ebwha/pdf_files/WHA67/A67_R6-en.pdf). Licence: CC BY-NC-SA 3.0 IGO.
- Issued
- 2014
- Type
- document
- As printed
- Resolution WHA67.6. Hepatitis. In: Sixty-seventh World Health Assembly, Geneva, 19–24 May 2014. Resolutions and decisions, annexes. Geneva: World Health Organization; 2014 (http://apps.who.int/gb/ebwha/pdf_files/WHA67/A67_R6-en.pdf). Licence: CC BY-NC-SA 3.0 IGO.
Sources
In the knowledge graph
- IRI
references/10665-385385.sec-007.2 - provenance: extracted
- read from
references/10665-385385.sec-007.2.json(who-iris, sub-graph who-iris-references) - derived from
library/10665-385385/sections/sec-007-references.md
-
Global health sector strategies on, respectively, HIV, viral hepatitis and sexually transmitted infections for the period 2022–2030. Geneva: World Health Organization; 2022:2022 (https://iris.who.int/handle/10665/360348).
· extracted · link · source:references/10665-385385.sec-007.3.jsonGlobal health sector strategies on, respectively, HIV, viral hepatitis and sexually transmitted infections for the period 2022–2030. Geneva: World Health Organization; 2022:2022 (https://iris.who.int/handle/10665/360348).
- Issued
- 2022
- Type
- document
- As printed
- Global health sector strategies on, respectively, HIV, viral hepatitis and sexually transmitted infections for the period 2022–2030. Geneva: World Health Organization; 2022:2022 (https://iris.who.int/handle/10665/360348).
Sources
- iris.who.int/handle/10665/360348 (canonical)
In the knowledge graph
- IRI
references/10665-385385.sec-007.3 - provenance: extracted
- read from
references/10665-385385.sec-007.3.json(who-iris, sub-graph who-iris-references) - derived from
library/10665-385385/sections/sec-007-references.md
-
Global health sector strategy on viral hepatitis 2016–2021. Towards ending viral hepatitis. Geneva, Switzerland: World Health Organization; 2016 (https://iris.who.int/handle/10665/246177). Licence: CC BY-NC-SA 3.0 IGO.
· extracted · link · source:references/10665-385385.sec-007.4.jsonGlobal health sector strategy on viral hepatitis 2016–2021. Towards ending viral hepatitis. Geneva, Switzerland: World Health Organization; 2016 (https://iris.who.int/handle/10665/246177). Licence: CC BY-NC-SA 3.0 IGO.
- Issued
- 2016
- Type
- document
- As printed
- Global health sector strategy on viral hepatitis 2016–2021. Towards ending viral hepatitis. Geneva, Switzerland: World Health Organization; 2016 (https://iris.who.int/handle/10665/246177). Licence: CC BY-NC-SA 3.0 IGO.
Sources
- iris.who.int/handle/10665/246177 (canonical)
In the knowledge graph
- IRI
references/10665-385385.sec-007.4 - provenance: extracted
- read from
references/10665-385385.sec-007.4.json(who-iris, sub-graph who-iris-references) - derived from
library/10665-385385/sections/sec-007-references.md
-
Zhuang H. Functional cure of chronic hepatitis B is not a dream. Journal of Clinical Hepatology. 2025;41(1):2 (https://doi.org/10.12449/jch250101).
· extracted · doi:10.12449/jch250101 · source:references/10665-385385.sec-007.5.jsonZhuang H. Functional cure of chronic hepatitis B is not a dream. Journal of Clinical Hepatology. 2025;41(1):2 (https://doi.org/10.12449/jch250101).
- Issued
- 2025
- Type
- article-journal
- DOI
- 10.12449/jch250101
- As printed
- Zhuang H. Functional cure of chronic hepatitis B is not a dream. Journal of Clinical Hepatology. 2025;41(1):2 (https://doi.org/10.12449/jch250101).
Sources
- doi:10.12449/jch250101 (doi)
In the knowledge graph
- IRI
references/10665-385385.sec-007.5 - provenance: extracted
- read from
references/10665-385385.sec-007.5.json(who-iris, sub-graph who-iris-references) - derived from
library/10665-385385/sections/sec-007-references.md
-
Costa GL, Sautto GA. Towards an HCV vaccine: an overview of the immunization strategies for eliciting an effective B-cell response. Expert Rev Vaccines. 2025;24(1):96-120 (https://doi.org/10.1080/14760584.2025.2452955).
· extracted · doi:10.1080/14760584.2025.2452955 · source:references/10665-385385.sec-007.6.jsonCosta GL, Sautto GA. Towards an HCV vaccine: an overview of the immunization strategies for eliciting an effective B-cell response. Expert Rev Vaccines. 2025;24(1):96-120 (https://doi.org/10.1080/14760584.2025.2452955).
- Issued
- 2025
- Type
- article-journal
- DOI
- 10.1080/14760584.2025.2452955
- As printed
- Costa GL, Sautto GA. Towards an HCV vaccine: an overview of the immunization strategies for eliciting an effective B-cell response. Expert Rev Vaccines. 2025;24(1):96-120 (https://doi.org/10.1080/14760584.2025.2452955).
Sources
In the knowledge graph
- IRI
references/10665-385385.sec-007.6 - provenance: extracted
- read from
references/10665-385385.sec-007.6.json(who-iris, sub-graph who-iris-references) - derived from
library/10665-385385/sections/sec-007-references.md
-
WHO R&D Blueprint for Epidemics [website]. World Health Organization; 2024 (https://www.who.int/teams/blueprint/who-r-and-d-blueprint-for-epidemics). Licence: CC BY-NC-SA 3.0 IGO.
· extracted · link · source:references/10665-385385.sec-007.7.jsonWHO R&D Blueprint for Epidemics [website]. World Health Organization; 2024 (https://www.who.int/teams/blueprint/who-r-and-d-blueprint-for-epidemics). Licence: CC BY-NC-SA 3.0 IGO.
- Issued
- 2024
- Type
- document
- As printed
- WHO R&D Blueprint for Epidemics [website]. World Health Organization; 2024 (https://www.who.int/teams/blueprint/who-r-and-d-blueprint-for-epidemics). Licence: CC BY-NC-SA 3.0 IGO.
Sources
In the knowledge graph
- IRI
references/10665-385385.sec-007.7 - provenance: extracted
- read from
references/10665-385385.sec-007.7.json(who-iris, sub-graph who-iris-references) - derived from
library/10665-385385/sections/sec-007-references.md
-
Global Reporting System for Hepatitis (GRSH): Project Description. Geneva: World Health Organization; 2016 (https://who-dev5.prgsdev.com/m/teams/global-hiv-hepatitis-and-stis-programmes/hepatitis/strategic-information/global-reporting-system). Licence: CC BY-NC-SA 3.0 IGO.
· extracted · link · source:references/10665-385385.sec-007.8.jsonGlobal Reporting System for Hepatitis (GRSH): Project Description. Geneva: World Health Organization; 2016 (https://who-dev5.prgsdev.com/m/teams/global-hiv-hepatitis-and-stis-programmes/hepatitis/strategic-information/global-reporting-system). Licence: CC BY-NC-SA 3.0 IGO.
- Issued
- 2016
- Type
- document
- As printed
- Global Reporting System for Hepatitis (GRSH): Project Description. Geneva: World Health Organization; 2016 (https://who-dev5.prgsdev.com/m/teams/global-hiv-hepatitis-and-stis-programmes/hepatitis/strategic-information/global-reporting-system). Licence: CC BY-NC-SA 3.0 IGO.
Sources
In the knowledge graph
- IRI
references/10665-385385.sec-007.8 - provenance: extracted
- read from
references/10665-385385.sec-007.8.json(who-iris, sub-graph who-iris-references) - derived from
library/10665-385385/sections/sec-007-references.md
-
Global hepatitis report 2017. Geneva: World Health Organization; 2017 (https://iris.who.int/handle/10665/255016). Licence: CC BY-NC-SA 3.0 IGO.
· extracted · link · source:references/10665-385385.sec-007.9.jsonGlobal hepatitis report 2017. Geneva: World Health Organization; 2017 (https://iris.who.int/handle/10665/255016). Licence: CC BY-NC-SA 3.0 IGO.
- Issued
- 2017
- Type
- document
- As printed
- Global hepatitis report 2017. Geneva: World Health Organization; 2017 (https://iris.who.int/handle/10665/255016). Licence: CC BY-NC-SA 3.0 IGO.
Sources
- iris.who.int/handle/10665/255016 (canonical)
In the knowledge graph
- IRI
references/10665-385385.sec-007.9 - provenance: extracted
- read from
references/10665-385385.sec-007.9.json(who-iris, sub-graph who-iris-references) - derived from
library/10665-385385/sections/sec-007-references.md
-
Progress report on HIV, viral hepatitis and sexually transmitted infections, 2021. Accountability for the global health sector strategies 2016–2021: actions for impact. Geneva: World Health Organization; 2021 (https://iris.who.int/handle/10665/341412). Licence: CC BY-NC-SA 3.0 IGO.
· extracted · link · source:references/10665-385385.sec-007.10.jsonProgress report on HIV, viral hepatitis and sexually transmitted infections, 2021. Accountability for the global health sector strategies 2016–2021: actions for impact. Geneva: World Health Organization; 2021 (https://iris.who.int/handle/10665/341412). Licence: CC BY-NC-SA 3.0 IGO.
- Issued
- 2021
- Type
- document
- As printed
- Progress report on HIV, viral hepatitis and sexually transmitted infections, 2021. Accountability for the global health sector strategies 2016–2021: actions for impact. Geneva: World Health Organization; 2021 (https://iris.who.int/handle/10665/341412). Licence: CC BY-NC-SA 3.0 IGO.
Sources
- iris.who.int/handle/10665/341412 (canonical)
In the knowledge graph
- IRI
references/10665-385385.sec-007.10 - provenance: extracted
- read from
references/10665-385385.sec-007.10.json(who-iris, sub-graph who-iris-references) - derived from
library/10665-385385/sections/sec-007-references.md
-
Global hepatitis report 2024: action for access in low- and middle-income countries. Geneva: World Health Organization; 2024 (https://iris.who.int/handle/10665/376461). Licence: CC BY-NC-SA 3.0 IGO.
· extracted · link · source:references/10665-385385.sec-007.11.jsonGlobal hepatitis report 2024: action for access in low- and middle-income countries. Geneva: World Health Organization; 2024 (https://iris.who.int/handle/10665/376461). Licence: CC BY-NC-SA 3.0 IGO.
- Issued
- 2024
- Type
- document
- As printed
- Global hepatitis report 2024: action for access in low- and middle-income countries. Geneva: World Health Organization; 2024 (https://iris.who.int/handle/10665/376461). Licence: CC BY-NC-SA 3.0 IGO.
Sources
- iris.who.int/handle/10665/376461 (canonical)
In the knowledge graph
- IRI
references/10665-385385.sec-007.11 - provenance: extracted
- read from
references/10665-385385.sec-007.11.json(who-iris, sub-graph who-iris-references) - derived from
library/10665-385385/sections/sec-007-references.md
-
The Global Health Observatory (hepatitis) [website]. World Health Organization; 2025 (https://www.who.int/data/gho/data/themes/chronic-viral-hepatitis).
· extracted · link · source:references/10665-385385.sec-007.12.jsonThe Global Health Observatory (hepatitis) [website]. World Health Organization; 2025 (https://www.who.int/data/gho/data/themes/chronic-viral-hepatitis).
- Issued
- 2025
- Type
- document
- As printed
- The Global Health Observatory (hepatitis) [website]. World Health Organization; 2025 (https://www.who.int/data/gho/data/themes/chronic-viral-hepatitis).
Sources
In the knowledge graph
- IRI
references/10665-385385.sec-007.12 - provenance: extracted
- read from
references/10665-385385.sec-007.12.json(who-iris, sub-graph who-iris-references) - derived from
library/10665-385385/sections/sec-007-references.md
-
Viral hepatitis country profiles [website]. World Health Organization; 2025 (https://data.who.int/dashboards/hepatitis/epidemiology).
· extracted · link · source:references/10665-385385.sec-007.13.jsonViral hepatitis country profiles [website]. World Health Organization; 2025 (https://data.who.int/dashboards/hepatitis/epidemiology).
- Issued
- 2025
- Type
- document
- As printed
- Viral hepatitis country profiles [website]. World Health Organization; 2025 (https://data.who.int/dashboards/hepatitis/epidemiology).
Sources
- data.who.int/dashboards/hepatitis/epidemiology (canonical)
In the knowledge graph
- IRI
references/10665-385385.sec-007.13 - provenance: extracted
- read from
references/10665-385385.sec-007.13.json(who-iris, sub-graph who-iris-references) - derived from
library/10665-385385/sections/sec-007-references.md
-
Hepatitis E background paper: SAGE March 2024. Geneva: World Health Organization; 2024 (https://cdn.who.int/media/docs/default-source/immunization/sage/2024/march/hepatitis_e_background_paper_sage_mar24.pdf?sfvrsn=e14438c4_1). Licence: CC BY-NC-SA 3.0 IGO.
· extracted · link · source:references/10665-385385.sec-007.14.jsonHepatitis E background paper: SAGE March 2024. Geneva: World Health Organization; 2024 (https://cdn.who.int/media/docs/default-source/immunization/sage/2024/march/hepatitis_e_background_paper_sage_mar24.pdf?sfvrsn=e14438c4_1). Licence: CC BY-NC-SA 3.0 IGO.
- Issued
- 2024
- Type
- document
- As printed
- Hepatitis E background paper: SAGE March 2024. Geneva: World Health Organization; 2024 (https://cdn.who.int/media/docs/default-source/immunization/sage/2024/march/hepatitis_e_background_paper_sage_mar24.pdf?sfvrsn=e14438c4_1). Licence: CC BY-NC-SA 3.0 IGO.
Sources
In the knowledge graph
- IRI
references/10665-385385.sec-007.14 - provenance: extracted
- read from
references/10665-385385.sec-007.14.json(who-iris, sub-graph who-iris-references) - derived from
library/10665-385385/sections/sec-007-references.md
-
World Health Assembly, 45 (1992). Forty-fifth World Health Assembly, Geneva, 4-14 May 1992: resolutions and decisions, annexes. Geneva: World Health Organization; 1992 (https://iris.who.int/handle/10665/175630).
· extracted · link · source:references/10665-385385.sec-007.15.jsonWorld Health Assembly, 45 (1992). Forty-fifth World Health Assembly, Geneva, 4-14 May 1992: resolutions and decisions, annexes. Geneva: World Health Organization; 1992 (https://iris.who.int/handle/10665/175630).
- Issued
- 1992
- Type
- document
- As printed
- World Health Assembly, 45 (1992). Forty-fifth World Health Assembly, Geneva, 4-14 May 1992: resolutions and decisions, annexes. Geneva: World Health Organization; 1992 (https://iris.who.int/handle/10665/175630).
Sources
- iris.who.int/handle/10665/175630 (canonical)
In the knowledge graph
- IRI
references/10665-385385.sec-007.15 - provenance: extracted
- read from
references/10665-385385.sec-007.15.json(who-iris, sub-graph who-iris-references) - derived from
library/10665-385385/sections/sec-007-references.md
-
World Health Assembly, 28 (1975). Twenty-eighth World Health Assembly, Geneva, 13-30 May 1975: part I: resolutions and decisions: annexes. Geneva: World Health Organization; 1975 (https://iris.who.int/handle/10665/86022).
· extracted · link · source:references/10665-385385.sec-007.16.jsonWorld Health Assembly, 28 (1975). Twenty-eighth World Health Assembly, Geneva, 13-30 May 1975: part I: resolutions and decisions: annexes. Geneva: World Health Organization; 1975 (https://iris.who.int/handle/10665/86022).
- Issued
- 1975
- Type
- document
- As printed
- World Health Assembly, 28 (1975). Twenty-eighth World Health Assembly, Geneva, 13-30 May 1975: part I: resolutions and decisions: annexes. Geneva: World Health Organization; 1975 (https://iris.who.int/handle/10665/86022).
Sources
- iris.who.int/handle/10665/86022 (canonical)
In the knowledge graph
- IRI
references/10665-385385.sec-007.16 - provenance: extracted
- read from
references/10665-385385.sec-007.16.json(who-iris, sub-graph who-iris-references) - derived from
library/10665-385385/sections/sec-007-references.md
-
Prevention and control of viral hepatitis infection: framework for global action. Geneva: World Health Organization; 2012 (https://iris.who.int/handle/10665/130012). Licence: CC BY-NC-SA 3.0 IGO.
· extracted · link · source:references/10665-385385.sec-007.17.jsonPrevention and control of viral hepatitis infection: framework for global action. Geneva: World Health Organization; 2012 (https://iris.who.int/handle/10665/130012). Licence: CC BY-NC-SA 3.0 IGO.
- Issued
- 2012
- Type
- document
- As printed
- Prevention and control of viral hepatitis infection: framework for global action. Geneva: World Health Organization; 2012 (https://iris.who.int/handle/10665/130012). Licence: CC BY-NC-SA 3.0 IGO.
Sources
- iris.who.int/handle/10665/130012 (canonical)
In the knowledge graph
- IRI
references/10665-385385.sec-007.17 - provenance: extracted
- read from
references/10665-385385.sec-007.17.json(who-iris, sub-graph who-iris-references) - derived from
library/10665-385385/sections/sec-007-references.md
-
Sustainable Development Goals-SDG Target 3.3 Communicable diseases [website]. United Nations; (https://sdgs.un.org/goals/goal3#targets_and_indicators).
· extracted · link · source:references/10665-385385.sec-007.18.jsonSustainable Development Goals-SDG Target 3.3 Communicable diseases [website]. United Nations; (https://sdgs.un.org/goals/goal3#targets_and_indicators).
- Type
- document
- As printed
- Sustainable Development Goals-SDG Target 3.3 Communicable diseases [website]. United Nations; (https://sdgs.un.org/goals/goal3#targets_and_indicators).
Sources
- sdgs.un.org/goals/goal3#targets_and_indicators (canonical)
In the knowledge graph
- IRI
references/10665-385385.sec-007.18 - provenance: extracted
- read from
references/10665-385385.sec-007.18.json(who-iris, sub-graph who-iris-references) - derived from
library/10665-385385/sections/sec-007-references.md
-
Nayagam S, Thursz M, Sicuri E, Conteh L, Wiktor S, Low-Beer D et al. Requirements for global elimination of hepatitis B: a modelling study. Lancet Infect Dis. 2016;16(12):1399-408 (https://doi.org/10.1016/S1473-3099(16)30204-3).
· extracted · doi:10.1016/S1473-3099(16)30204-3 · source:references/10665-385385.sec-007.19.jsonNayagam S, Thursz M, Sicuri E, Conteh L, Wiktor S, Low-Beer D et al. Requirements for global elimination of hepatitis B: a modelling study. Lancet Infect Dis. 2016;16(12):1399-408 (https://doi.org/10.1016/S1473-3099(16)30204-3).
- Issued
- 2016
- Type
- article-journal
- DOI
- 10.1016/S1473-3099(16)30204-3
- As printed
- Nayagam S, Thursz M, Sicuri E, Conteh L, Wiktor S, Low-Beer D et al. Requirements for global elimination of hepatitis B: a modelling study. Lancet Infect Dis. 2016;16(12):1399-408 (https://doi.org/10.1016/S1473-3099(16)30204-3).
Sources
In the knowledge graph
- IRI
references/10665-385385.sec-007.19 - provenance: extracted
- read from
references/10665-385385.sec-007.19.json(who-iris, sub-graph who-iris-references) - derived from
library/10665-385385/sections/sec-007-references.md
-
Combating hepatitis B and C to reach elimination by 2030: advocacy brief. Geneva, Switzerland: World Health Organization; 2016 ( https://iris.who.int/handle/10665/206453).
· extracted · link · source:references/10665-385385.sec-007.20.jsonCombating hepatitis B and C to reach elimination by 2030: advocacy brief. Geneva, Switzerland: World Health Organization; 2016 ( https://iris.who.int/handle/10665/206453).
- Issued
- 2016
- Type
- document
- As printed
- Combating hepatitis B and C to reach elimination by 2030: advocacy brief. Geneva, Switzerland: World Health Organization; 2016 ( https://iris.who.int/handle/10665/206453).
Sources
- iris.who.int/handle/10665/206453 (canonical)
In the knowledge graph
- IRI
references/10665-385385.sec-007.20 - provenance: extracted
- read from
references/10665-385385.sec-007.20.json(who-iris, sub-graph who-iris-references) - derived from
library/10665-385385/sections/sec-007-references.md
-
World Health Assembly, 75 (2022). Seventy-fifth World Health Assembly: Geneva, 22-28 May 2022: summary records of committees, reports of committees. Geneva: World Health Organization; 2022 (https://iris.who.int/handle/10665/365611). Licence: CC BY-NC-SA 3.0 IGO. 72 | Global hepatitis report 2026
· extracted · link · source:references/10665-385385.sec-007.21.jsonWorld Health Assembly, 75 (2022). Seventy-fifth World Health Assembly: Geneva, 22-28 May 2022: summary records of committees, reports of committees. Geneva: World Health Organization; 2022 (https://iris.who.int/handle/10665/365611). Licence: CC BY-NC-SA 3.0 IGO. 72 | Global hepatitis report 2026
- Issued
- 2026
- Type
- document
- As printed
- World Health Assembly, 75 (2022). Seventy-fifth World Health Assembly: Geneva, 22-28 May 2022: summary records of committees, reports of committees. Geneva: World Health Organization; 2022 (https://iris.who.int/handle/10665/365611). Licence: CC BY-NC-SA 3.0 IGO. 72 | Global hepatitis report 2026
Sources
- iris.who.int/handle/10665/365611 (canonical)
In the knowledge graph
- IRI
references/10665-385385.sec-007.21 - provenance: extracted
- read from
references/10665-385385.sec-007.21.json(who-iris, sub-graph who-iris-references) - derived from
library/10665-385385/sections/sec-007-references.md
-
Guidance for country validation of viral hepatitis elimination and path to elimination: technical report. Geneva: World Health Organization; 2023 (https://iris.who.int/handle/10665/373186). Licence: CC BY-NC-SA 3.0 IGO.
· extracted · link · source:references/10665-385385.sec-007.22.jsonGuidance for country validation of viral hepatitis elimination and path to elimination: technical report. Geneva: World Health Organization; 2023 (https://iris.who.int/handle/10665/373186). Licence: CC BY-NC-SA 3.0 IGO.
- Issued
- 2023
- Type
- document
- As printed
- Guidance for country validation of viral hepatitis elimination and path to elimination: technical report. Geneva: World Health Organization; 2023 (https://iris.who.int/handle/10665/373186). Licence: CC BY-NC-SA 3.0 IGO.
Sources
- iris.who.int/handle/10665/373186 (canonical)
In the knowledge graph
- IRI
references/10665-385385.sec-007.22 - provenance: extracted
- read from
references/10665-385385.sec-007.22.json(who-iris, sub-graph who-iris-references) - derived from
library/10665-385385/sections/sec-007-references.md
-
Guidelines for the prevention, care and treatment of persons with chronic hepatitis B infection. Geneva: World Health Organization; 2015 (https://iris.who.int/handle/10665/154590). Licence: CC BY-NC-SA 3.0 IGO.
· extracted · link · source:references/10665-385385.sec-007.23.jsonGuidelines for the prevention, care and treatment of persons with chronic hepatitis B infection. Geneva: World Health Organization; 2015 (https://iris.who.int/handle/10665/154590). Licence: CC BY-NC-SA 3.0 IGO.
- Issued
- 2015
- Type
- document
- As printed
- Guidelines for the prevention, care and treatment of persons with chronic hepatitis B infection. Geneva: World Health Organization; 2015 (https://iris.who.int/handle/10665/154590). Licence: CC BY-NC-SA 3.0 IGO.
Sources
- iris.who.int/handle/10665/154590 (canonical)
In the knowledge graph
- IRI
references/10665-385385.sec-007.23 - provenance: extracted
- read from
references/10665-385385.sec-007.23.json(who-iris, sub-graph who-iris-references) - derived from
library/10665-385385/sections/sec-007-references.md
-
Preventing perinatal hepatitis B virus transmission: a guide for introducing and strengthening hepatitis B birth dose vaccination. Geneva: World Health Organization; 2015 (https://iris.who.int/handle/10665/208278 ). Licence: CC BY-NC-SA 3.0 IGO.
· extracted · link · source:references/10665-385385.sec-007.24.jsonPreventing perinatal hepatitis B virus transmission: a guide for introducing and strengthening hepatitis B birth dose vaccination. Geneva: World Health Organization; 2015 (https://iris.who.int/handle/10665/208278 ). Licence: CC BY-NC-SA 3.0 IGO.
- Issued
- 2015
- Type
- document
- As printed
- Preventing perinatal hepatitis B virus transmission: a guide for introducing and strengthening hepatitis B birth dose vaccination. Geneva: World Health Organization; 2015 (https://iris.who.int/handle/10665/208278 ). Licence: CC BY-NC-SA 3.0 IGO.
Sources
- iris.who.int/handle/10665/208278 (canonical)
In the knowledge graph
- IRI
references/10665-385385.sec-007.24 - provenance: extracted
- read from
references/10665-385385.sec-007.24.json(who-iris, sub-graph who-iris-references) - derived from
library/10665-385385/sections/sec-007-references.md
-
Guidelines for the screening, care and treatment of persons with chronic hepatitis C infection, Updated version, April 2016. Geneva: World Health Organization; 2016 (https://iris.who.int/handle/10665/205035). Licence: CC
· extracted · link · source:references/10665-385385.sec-007.25.jsonGuidelines for the screening, care and treatment of persons with chronic hepatitis C infection, Updated version, April 2016. Geneva: World Health Organization; 2016 (https://iris.who.int/handle/10665/205035). Licence: CC
- Issued
- 2016
- Type
- document
- As printed
- Guidelines for the screening, care and treatment of persons with chronic hepatitis C infection, Updated version, April 2016. Geneva: World Health Organization; 2016 (https://iris.who.int/handle/10665/205035). Licence: CC
Sources
- iris.who.int/handle/10665/205035 (canonical)
In the knowledge graph
- IRI
references/10665-385385.sec-007.25 - provenance: extracted
- read from
references/10665-385385.sec-007.25.json(who-iris, sub-graph who-iris-references) - derived from
library/10665-385385/sections/sec-007-references.md
-
World Health Organization. Hepatitis B vaccines: WHO position paper, July 2017 – recommendations. Vaccine. 2019;37(2):223–5 (https://doi.org/10.1016/j.vaccine.2017.07.046).
· extracted · doi:10.1016/j.vaccine.2017.07.046 · source:references/10665-385385.sec-007.26.jsonWorld Health Organization. Hepatitis B vaccines: WHO position paper, July 2017 – recommendations. Vaccine. 2019;37(2):223–5 (https://doi.org/10.1016/j.vaccine.2017.07.046).
- Issued
- 2019
- Type
- article-journal
- DOI
- 10.1016/j.vaccine.2017.07.046
- As printed
- World Health Organization. Hepatitis B vaccines: WHO position paper, July 2017 – recommendations. Vaccine. 2019;37(2):223–5 (https://doi.org/10.1016/j.vaccine.2017.07.046).
Sources
In the knowledge graph
- IRI
references/10665-385385.sec-007.26 - provenance: extracted
- read from
references/10665-385385.sec-007.26.json(who-iris, sub-graph who-iris-references) - derived from
library/10665-385385/sections/sec-007-references.md
-
Monitoring and evaluation for viral hepatitis B and C: recommended indicators and framework. Geneva: World Health Organization; 2016 (https://iris.who.int/handle/10665/204790). Licence: CC BY-NC-SA 3.0 IGO.
· extracted · link · source:references/10665-385385.sec-007.27.jsonMonitoring and evaluation for viral hepatitis B and C: recommended indicators and framework. Geneva: World Health Organization; 2016 (https://iris.who.int/handle/10665/204790). Licence: CC BY-NC-SA 3.0 IGO.
- Issued
- 2016
- Type
- document
- As printed
- Monitoring and evaluation for viral hepatitis B and C: recommended indicators and framework. Geneva: World Health Organization; 2016 (https://iris.who.int/handle/10665/204790). Licence: CC BY-NC-SA 3.0 IGO.
Sources
- iris.who.int/handle/10665/204790 (canonical)
In the knowledge graph
- IRI
references/10665-385385.sec-007.27 - provenance: extracted
- read from
references/10665-385385.sec-007.27.json(who-iris, sub-graph who-iris-references) - derived from
library/10665-385385/sections/sec-007-references.md
-
WHO guidelines on hepatitis B and C testing. Geneva: World Health Organization; 2017 (https://iris.who.int/handle/10665/254621). Licence: CC BY-NC-SA 3.0 IGO.
· extracted · link · source:references/10665-385385.sec-007.28.jsonWHO guidelines on hepatitis B and C testing. Geneva: World Health Organization; 2017 (https://iris.who.int/handle/10665/254621). Licence: CC BY-NC-SA 3.0 IGO.
- Issued
- 2017
- Type
- document
- As printed
- WHO guidelines on hepatitis B and C testing. Geneva: World Health Organization; 2017 (https://iris.who.int/handle/10665/254621). Licence: CC BY-NC-SA 3.0 IGO.
Sources
- iris.who.int/handle/10665/254621 (canonical)
In the knowledge graph
- IRI
references/10665-385385.sec-007.28 - provenance: extracted
- read from
references/10665-385385.sec-007.28.json(who-iris, sub-graph who-iris-references) - derived from
library/10665-385385/sections/sec-007-references.md
-
Guidelines for the care and treatment of persons diagnosed with chronic hepatitis C virus infection. Geneva: World Health Organization; 2018 (https://iris.who.int/handle/10665/273174). Licence: CC BY-NC-SA 3.0 IGO
· extracted · link · source:references/10665-385385.sec-007.29.jsonGuidelines for the care and treatment of persons diagnosed with chronic hepatitis C virus infection. Geneva: World Health Organization; 2018 (https://iris.who.int/handle/10665/273174). Licence: CC BY-NC-SA 3.0 IGO
- Issued
- 2018
- Type
- document
- As printed
- Guidelines for the care and treatment of persons diagnosed with chronic hepatitis C virus infection. Geneva: World Health Organization; 2018 (https://iris.who.int/handle/10665/273174). Licence: CC BY-NC-SA 3.0 IGO
Sources
- iris.who.int/handle/10665/273174 (canonical)
In the knowledge graph
- IRI
references/10665-385385.sec-007.29 - provenance: extracted
- read from
references/10665-385385.sec-007.29.json(who-iris, sub-graph who-iris-references) - derived from
library/10665-385385/sections/sec-007-references.md
-
elimination: guidelines. Geneva: World Health Organization; 2019 (https://iris.who.int/handle/10665/310912).
· extracted · link · source:references/10665-385385.sec-007.30.jsonelimination: guidelines. Geneva: World Health Organization; 2019 (https://iris.who.int/handle/10665/310912).
- Issued
- 2019
- Type
- document
- As printed
- elimination: guidelines. Geneva: World Health Organization; 2019 (https://iris.who.int/handle/10665/310912).
Sources
- iris.who.int/handle/10665/310912 (canonical)
In the knowledge graph
- IRI
references/10665-385385.sec-007.30 - provenance: extracted
- read from
references/10665-385385.sec-007.30.json(who-iris, sub-graph who-iris-references) - derived from
library/10665-385385/sections/sec-007-references.md
-
elimination: web annex 1: standard operating procedures (SOPs) for enhanced reporting of cases of acute hepatitis. Geneva: World Health Organization; 2019 (https://iris.who.int/handle/10665/280098). Licence: CC
· extracted · link · source:references/10665-385385.sec-007.31.jsonelimination: web annex 1: standard operating procedures (SOPs) for enhanced reporting of cases of acute hepatitis. Geneva: World Health Organization; 2019 (https://iris.who.int/handle/10665/280098). Licence: CC
- Issued
- 2019
- Type
- document
- As printed
- elimination: web annex 1: standard operating procedures (SOPs) for enhanced reporting of cases of acute hepatitis. Geneva: World Health Organization; 2019 (https://iris.who.int/handle/10665/280098). Licence: CC
Sources
- iris.who.int/handle/10665/280098 (canonical)
In the knowledge graph
- IRI
references/10665-385385.sec-007.31 - provenance: extracted
- read from
references/10665-385385.sec-007.31.json(who-iris, sub-graph who-iris-references) - derived from
library/10665-385385/sections/sec-007-references.md
-
elimination: web annex 2: template protocol for surveys to estimate the prevalence of biomarkers of infection with the hepatitis viruses. Geneva: World Health Organization; 2019 (https://iris.who.int/handle/10665/280099).
· extracted · link · source:references/10665-385385.sec-007.32.jsonelimination: web annex 2: template protocol for surveys to estimate the prevalence of biomarkers of infection with the hepatitis viruses. Geneva: World Health Organization; 2019 (https://iris.who.int/handle/10665/280099).
- Issued
- 2019
- Type
- document
- As printed
- elimination: web annex 2: template protocol for surveys to estimate the prevalence of biomarkers of infection with the hepatitis viruses. Geneva: World Health Organization; 2019 (https://iris.who.int/handle/10665/280099).
Sources
- iris.who.int/handle/10665/280099 (canonical)
In the knowledge graph
- IRI
references/10665-385385.sec-007.32 - provenance: extracted
- read from
references/10665-385385.sec-007.32.json(who-iris, sub-graph who-iris-references) - derived from
library/10665-385385/sections/sec-007-references.md
-
Prevention of mother-to-child transmission of hepatitis B virus: guidelines on antiviral prophylaxis in pregnancy. Geneva: World Health Organization; 2020 (https://iris.who.int/handle/10665/333391). Licence: CC BY-NC-SA 3.0
· extracted · link · source:references/10665-385385.sec-007.33.jsonPrevention of mother-to-child transmission of hepatitis B virus: guidelines on antiviral prophylaxis in pregnancy. Geneva: World Health Organization; 2020 (https://iris.who.int/handle/10665/333391). Licence: CC BY-NC-SA 3.0
- Issued
- 2020
- Type
- document
- As printed
- Prevention of mother-to-child transmission of hepatitis B virus: guidelines on antiviral prophylaxis in pregnancy. Geneva: World Health Organization; 2020 (https://iris.who.int/handle/10665/333391). Licence: CC BY-NC-SA 3.0
Sources
- iris.who.int/handle/10665/333391 (canonical)
In the knowledge graph
- IRI
references/10665-385385.sec-007.33 - provenance: extracted
- read from
references/10665-385385.sec-007.33.json(who-iris, sub-graph who-iris-references) - derived from
library/10665-385385/sections/sec-007-references.md
-
Recommendations and guidance on hepatitis C virus self-testing. Geneva: World Health Organization; 2021 (https://iris.who.int/handle/10665/342803). Licence: CC BY-NC-SA 3.0 IGO.
· extracted · link · source:references/10665-385385.sec-007.34.jsonRecommendations and guidance on hepatitis C virus self-testing. Geneva: World Health Organization; 2021 (https://iris.who.int/handle/10665/342803). Licence: CC BY-NC-SA 3.0 IGO.
- Issued
- 2021
- Type
- document
- As printed
- Recommendations and guidance on hepatitis C virus self-testing. Geneva: World Health Organization; 2021 (https://iris.who.int/handle/10665/342803). Licence: CC BY-NC-SA 3.0 IGO.
Sources
- iris.who.int/handle/10665/342803 (canonical)
In the knowledge graph
- IRI
references/10665-385385.sec-007.34 - provenance: extracted
- read from
references/10665-385385.sec-007.34.json(who-iris, sub-graph who-iris-references) - derived from
library/10665-385385/sections/sec-007-references.md
-
Updated recommendations on treatment of adolescents and children with chronic HCV infection, and HCV simplified service delivery and diagnostics. Geneva: World Health Organization; 2022 (https://iris.who.int/handle/10665/363590). Licence: CC BY-NC-SA 3.0 IGO.
· extracted · link · source:references/10665-385385.sec-007.35.jsonUpdated recommendations on treatment of adolescents and children with chronic HCV infection, and HCV simplified service delivery and diagnostics. Geneva: World Health Organization; 2022 (https://iris.who.int/handle/10665/363590). Licence: CC BY-NC-SA 3.0 IGO.
- Issued
- 2022
- Type
- document
- As printed
- Updated recommendations on treatment of adolescents and children with chronic HCV infection, and HCV simplified service delivery and diagnostics. Geneva: World Health Organization; 2022 (https://iris.who.int/handle/10665/363590). Licence: CC BY-NC-SA 3.0 IGO.
Sources
- iris.who.int/handle/10665/363590 (canonical)
In the knowledge graph
- IRI
references/10665-385385.sec-007.35 - provenance: extracted
- read from
references/10665-385385.sec-007.35.json(who-iris, sub-graph who-iris-references) - derived from
library/10665-385385/sections/sec-007-references.md
-
Consolidated guidelines on HIV, viral hepatitis and STI prevention, diagnosis, treatment and care for key populations. Geneva: World Health Organization; 2022 (https://iris.who.int/handle/10665/360601). Licence: CC
· extracted · link · source:references/10665-385385.sec-007.36.json· held:library/10665-360601Consolidated guidelines on HIV, viral hepatitis and STI prevention, diagnosis, treatment and care for key populations. Geneva: World Health Organization; 2022 (https://iris.who.int/handle/10665/360601). Licence: CC
- Issued
- 2022
- Type
- document
- As printed
- Consolidated guidelines on HIV, viral hepatitis and STI prevention, diagnosis, treatment and care for key populations. Geneva: World Health Organization; 2022 (https://iris.who.int/handle/10665/360601). Licence: CC
Sources
- iris.who.int/handle/10665/360601 (canonical)
In the knowledge graph
- IRI
references/10665-385385.sec-007.36 - provenance: extracted
- read from
references/10665-385385.sec-007.36.json(who-iris, sub-graph who-iris-references) - derived from
library/10665-385385/sections/sec-007-references.md - library copy:
library/10665-360601
-
Guidance for national strategic planning (NSP): health sector response to HIV, viral hepatitis and sexually transmitted infections. Geneva: World Health Organization; 2023 (https://iris.who.int/handle/10665/373523).
· extracted · link · source:references/10665-385385.sec-007.37.jsonGuidance for national strategic planning (NSP): health sector response to HIV, viral hepatitis and sexually transmitted infections. Geneva: World Health Organization; 2023 (https://iris.who.int/handle/10665/373523).
- Issued
- 2023
- Type
- document
- As printed
- Guidance for national strategic planning (NSP): health sector response to HIV, viral hepatitis and sexually transmitted infections. Geneva: World Health Organization; 2023 (https://iris.who.int/handle/10665/373523).
Sources
- iris.who.int/handle/10665/373523 (canonical)
In the knowledge graph
- IRI
references/10665-385385.sec-007.37 - provenance: extracted
- read from
references/10665-385385.sec-007.37.json(who-iris, sub-graph who-iris-references) - derived from
library/10665-385385/sections/sec-007-references.md
-
Guidelines for the prevention, diagnosis, care and treatment for people with chronic hepatitis B infection. Geneva: World Health Organization; 2024 (https://iris.who.int/handle/10665/376353). Licence: CC BY-NC-SA 3.0
· extracted · link · source:references/10665-385385.sec-007.38.jsonGuidelines for the prevention, diagnosis, care and treatment for people with chronic hepatitis B infection. Geneva: World Health Organization; 2024 (https://iris.who.int/handle/10665/376353). Licence: CC BY-NC-SA 3.0
- Issued
- 2024
- Type
- document
- As printed
- Guidelines for the prevention, diagnosis, care and treatment for people with chronic hepatitis B infection. Geneva: World Health Organization; 2024 (https://iris.who.int/handle/10665/376353). Licence: CC BY-NC-SA 3.0
Sources
- iris.who.int/handle/10665/376353 (canonical)
In the knowledge graph
- IRI
references/10665-385385.sec-007.38 - provenance: extracted
- read from
references/10665-385385.sec-007.38.json(who-iris, sub-graph who-iris-references) - derived from
library/10665-385385/sections/sec-007-references.md
-
Consolidated guidelines on person-centred viral hepatitis strategic information: using data to support country scale-up of hepatitis prevention, diagnosis and treatment services. Geneva: World Health Organization; 2024 (https://iris.who.int/handle/10665/376410). Licence: CC BY-NC-SA 3.0 IGO.
· extracted · link · source:references/10665-385385.sec-007.39.jsonConsolidated guidelines on person-centred viral hepatitis strategic information: using data to support country scale-up of hepatitis prevention, diagnosis and treatment services. Geneva: World Health Organization; 2024 (https://iris.who.int/handle/10665/376410). Licence: CC BY-NC-SA 3.0 IGO.
- Issued
- 2024
- Type
- document
- As printed
- Consolidated guidelines on person-centred viral hepatitis strategic information: using data to support country scale-up of hepatitis prevention, diagnosis and treatment services. Geneva: World Health Organization; 2024 (https://iris.who.int/handle/10665/376410). Licence: CC BY-NC-SA 3.0 IGO.
Sources
- iris.who.int/handle/10665/376410 (canonical)
In the knowledge graph
- IRI
references/10665-385385.sec-007.39 - provenance: extracted
- read from
references/10665-385385.sec-007.39.json(who-iris, sub-graph who-iris-references) - derived from
library/10665-385385/sections/sec-007-references.md
-
Priorities in planning person-centred hepatitis B and C testing services: operational guide. Geneva: World Health Organization; 2024 (https://iris.who.int/handle/10665/379688). Licence: CC BY-NC-SA 3.0 IGO.
· extracted · link · source:references/10665-385385.sec-007.40.jsonPriorities in planning person-centred hepatitis B and C testing services: operational guide. Geneva: World Health Organization; 2024 (https://iris.who.int/handle/10665/379688). Licence: CC BY-NC-SA 3.0 IGO.
- Issued
- 2024
- Type
- document
- As printed
- Priorities in planning person-centred hepatitis B and C testing services: operational guide. Geneva: World Health Organization; 2024 (https://iris.who.int/handle/10665/379688). Licence: CC BY-NC-SA 3.0 IGO.
Sources
- iris.who.int/handle/10665/379688 (canonical)
In the knowledge graph
- IRI
references/10665-385385.sec-007.40 - provenance: extracted
- read from
references/10665-385385.sec-007.40.json(who-iris, sub-graph who-iris-references) - derived from
library/10665-385385/sections/sec-007-references.md
-
World Health Organization & United Nations Children's Fund (UNICEF). Country guidance for planning triple elimination of mother-to-child transmission of HIV, syphilis and hepatitis B virus programmes. Geneva: World Health Organization; 2025 (https://iris.who.int/handle/10665/381914). Licence: CC BY-NC-SA 3.0 IGO.
· extracted · link · source:references/10665-385385.sec-007.41.jsonWorld Health Organization & United Nations Children's Fund (UNICEF). Country guidance for planning triple elimination of mother-to-child transmission of HIV, syphilis and hepatitis B virus programmes. Geneva: World Health Organization; 2025 (https://iris.who.int/handle/10665/381914). Licence: CC BY-NC-SA 3.0 IGO.
- Issued
- 2025
- Type
- document
- As printed
- World Health Organization & United Nations Children's Fund (UNICEF). Country guidance for planning triple elimination of mother-to-child transmission of HIV, syphilis and hepatitis B virus programmes. Geneva: World Health Organization; 2025 (https://iris.who.int/handle/10665/381914). Licence: CC BY-NC-SA 3.0 IGO.
Sources
- iris.who.int/handle/10665/381914 (canonical)
In the knowledge graph
- IRI
references/10665-385385.sec-007.41 - provenance: extracted
- read from
references/10665-385385.sec-007.41.json(who-iris, sub-graph who-iris-references) - derived from
library/10665-385385/sections/sec-007-references.md
-
Consolidated guidance on hepatitis B and C prevention, testing, treatment, service delivery and monitoring: an implementation handbook for a public health approach. Geneva: World Health Organization; 2026 ( https://iris.who.int/handle/10665/384902). Licence: CC BY-NC-SA 3.0 IGO.
· extracted · link · source:references/10665-385385.sec-007.42.jsonConsolidated guidance on hepatitis B and C prevention, testing, treatment, service delivery and monitoring: an implementation handbook for a public health approach. Geneva: World Health Organization; 2026 ( https://iris.who.int/handle/10665/384902). Licence: CC BY-NC-SA 3.0 IGO.
- Issued
- 2026
- Type
- document
- As printed
- Consolidated guidance on hepatitis B and C prevention, testing, treatment, service delivery and monitoring: an implementation handbook for a public health approach. Geneva: World Health Organization; 2026 ( https://iris.who.int/handle/10665/384902). Licence: CC BY-NC-SA 3.0 IGO.
Sources
- iris.who.int/handle/10665/384902 (canonical)
In the knowledge graph
- IRI
references/10665-385385.sec-007.42 - provenance: extracted
- read from
references/10665-385385.sec-007.42.json(who-iris, sub-graph who-iris-references) - derived from
library/10665-385385/sections/sec-007-references.md
-
Fattovich G, Bortolotti F, Donato F. Natural history of chronic hepatitis B: special emphasis on disease progression and prognostic factors. J Hepatol. 2008;48(2):335-52 (https://doi.org/10.1016/j.jhep.2007.11.011).
· extracted · doi:10.1016/j.jhep.2007.11.011 · source:references/10665-385385.sec-007.43.jsonFattovich G, Bortolotti F, Donato F. Natural history of chronic hepatitis B: special emphasis on disease progression and prognostic factors. J Hepatol. 2008;48(2):335-52 (https://doi.org/10.1016/j.jhep.2007.11.011).
- Issued
- 2008
- Type
- article-journal
- DOI
- 10.1016/j.jhep.2007.11.011
- As printed
- Fattovich G, Bortolotti F, Donato F. Natural history of chronic hepatitis B: special emphasis on disease progression and prognostic factors. J Hepatol. 2008;48(2):335-52 (https://doi.org/10.1016/j.jhep.2007.11.011).
Sources
In the knowledge graph
- IRI
references/10665-385385.sec-007.43 - provenance: extracted
- read from
references/10665-385385.sec-007.43.json(who-iris, sub-graph who-iris-references) - derived from
library/10665-385385/sections/sec-007-references.md
-
Westbrook RH, Dusheiko G. Natural history of hepatitis C. J Hepatol. 2014;61(1 Suppl):S58-68 (https://doi.org/10.1016/j.jhep.2014.07.012).| 73
· extracted · doi:10.1016/j.jhep.2014.07.012).| · source:references/10665-385385.sec-007.44.jsonWestbrook RH, Dusheiko G. Natural history of hepatitis C. J Hepatol. 2014;61(1 Suppl):S58-68 (https://doi.org/10.1016/j.jhep.2014.07.012).| 73
- Issued
- 2014
- Type
- document
- DOI
- 10.1016/j.jhep.2014.07.012).|
- As printed
- Westbrook RH, Dusheiko G. Natural history of hepatitis C. J Hepatol. 2014;61(1 Suppl):S58-68 (https://doi.org/10.1016/j.jhep.2014.07.012).| 73
Sources
In the knowledge graph
- IRI
references/10665-385385.sec-007.44 - provenance: extracted
- read from
references/10665-385385.sec-007.44.json(who-iris, sub-graph who-iris-references) - derived from
library/10665-385385/sections/sec-007-references.md
-
McMahon BJ. The natural history of chronic hepatitis B virus infection. Hepatology. 2009;49(5 Suppl):S45-55 (https://doi.org/10.1002/hep.22898).
· extracted · doi:10.1002/hep.22898 · source:references/10665-385385.sec-007.45.jsonMcMahon BJ. The natural history of chronic hepatitis B virus infection. Hepatology. 2009;49(5 Suppl):S45-55 (https://doi.org/10.1002/hep.22898).
- Issued
- 2009
- Type
- document
- DOI
- 10.1002/hep.22898
- As printed
- McMahon BJ. The natural history of chronic hepatitis B virus infection. Hepatology. 2009;49(5 Suppl):S45-55 (https://doi.org/10.1002/hep.22898).
Sources
- doi:10.1002/hep.22898 (doi)
In the knowledge graph
- IRI
references/10665-385385.sec-007.45 - provenance: extracted
- read from
references/10665-385385.sec-007.45.json(who-iris, sub-graph who-iris-references) - derived from
library/10665-385385/sections/sec-007-references.md
-
Edmunds W, Medley G, Nokes D, Hall A, Whittle H. The influence of age on the development of the hepatitis B carrier state. Proceedings of the Royal Society of London Series B: Biological Sciences. 1993;253(1337):197-201 (https://doi.org/10.1098/rspb.1993.0102 ).
· extracted · doi:10.1098/rspb.1993.0102 · source:references/10665-385385.sec-007.46.jsonEdmunds W, Medley G, Nokes D, Hall A, Whittle H. The influence of age on the development of the hepatitis B carrier state. Proceedings of the Royal Society of London Series B: Biological Sciences. 1993;253(1337):197-201 (https://doi.org/10.1098/rspb.1993.0102 ).
- Issued
- 1993
- Type
- article-journal
- DOI
- 10.1098/rspb.1993.0102
- As printed
- Edmunds W, Medley G, Nokes D, Hall A, Whittle H. The influence of age on the development of the hepatitis B carrier state. Proceedings of the Royal Society of London Series B: Biological Sciences. 1993;253(1337):197-201 (https://doi.org/10.1098/rspb.1993.0102 ).
Sources
In the knowledge graph
- IRI
references/10665-385385.sec-007.46 - provenance: extracted
- read from
references/10665-385385.sec-007.46.json(who-iris, sub-graph who-iris-references) - derived from
library/10665-385385/sections/sec-007-references.md
-
Artenie A, Trickey A, Looker KJ, Stone J, Lim AG, Fraser H et al. Global, regional, and national estimates of hepatitis C virus (HCV) infection incidence among people who inject drugs and number of new annual HCV infections attributable to injecting drug use: a multi-stage analysis. Lancet Gastroenterol Hepatol. 2025;10(4):315-31 (https://doi.org/10.1016/s2468-1253(24)00442-4). PMICD:PMC12179389).
· extracted · doi:10.1016/s2468-1253(24)00442-4 · source:references/10665-385385.sec-007.47.jsonArtenie A, Trickey A, Looker KJ, Stone J, Lim AG, Fraser H et al. Global, regional, and national estimates of hepatitis C virus (HCV) infection incidence among people who inject drugs and number of new annual HCV infections attributable to injecting drug use: a multi-stage analysis. Lancet Gastroenterol Hepatol. 2025;10(4):315-31 (https://doi.org/10.1016/s2468-1253(24)00442-4). PMICD:PMC12179389).
- Issued
- 2025
- Type
- article-journal
- DOI
- 10.1016/s2468-1253(24)00442-4
- As printed
- Artenie A, Trickey A, Looker KJ, Stone J, Lim AG, Fraser H et al. Global, regional, and national estimates of hepatitis C virus (HCV) infection incidence among people who inject drugs and number of new annual HCV infections attributable to injecting drug use: a multi-stage analysis. Lancet Gastroenterol Hepatol. 2025;10(4):315-31 (https://doi.org/10.1016/s2468-1253(24)00442-4). PMICD:PMC12179389).
Sources
In the knowledge graph
- IRI
references/10665-385385.sec-007.47 - provenance: extracted
- read from
references/10665-385385.sec-007.47.json(who-iris, sub-graph who-iris-references) - derived from
library/10665-385385/sections/sec-007-references.md
-
Cousins S. Egypt's hepatitis success story. Lancet. 2024;403(10431):1011-2 (https://doi.org/10.1016/S0140-6736(24)00531-2).
· extracted · doi:10.1016/S0140-6736(24)00531-2 · source:references/10665-385385.sec-007.48.jsonCousins S. Egypt's hepatitis success story. Lancet. 2024;403(10431):1011-2 (https://doi.org/10.1016/S0140-6736(24)00531-2).
- Issued
- 2024
- Type
- article-journal
- DOI
- 10.1016/S0140-6736(24)00531-2
- As printed
- Cousins S. Egypt's hepatitis success story. Lancet. 2024;403(10431):1011-2 (https://doi.org/10.1016/S0140-6736(24)00531-2).
Sources
In the knowledge graph
- IRI
references/10665-385385.sec-007.48 - provenance: extracted
- read from
references/10665-385385.sec-007.48.json(who-iris, sub-graph who-iris-references) - derived from
library/10665-385385/sections/sec-007-references.md
-
Frank C, Mohamed MK, Strickland GT, Lavanchy D, Arthur RR, Magder LS et al. The role of parenteral antischistosomal therapy in the spread of hepatitis C virus in Egypt. Lancet. 2000;355(9207):887-91 (https://doi.org/10.1016/s0140-6736(99)06527-7).
· extracted · doi:10.1016/s0140-6736(99)06527-7 · source:references/10665-385385.sec-007.49.jsonFrank C, Mohamed MK, Strickland GT, Lavanchy D, Arthur RR, Magder LS et al. The role of parenteral antischistosomal therapy in the spread of hepatitis C virus in Egypt. Lancet. 2000;355(9207):887-91 (https://doi.org/10.1016/s0140-6736(99)06527-7).
- Issued
- 2000
- Type
- article-journal
- DOI
- 10.1016/s0140-6736(99)06527-7
- As printed
- Frank C, Mohamed MK, Strickland GT, Lavanchy D, Arthur RR, Magder LS et al. The role of parenteral antischistosomal therapy in the spread of hepatitis C virus in Egypt. Lancet. 2000;355(9207):887-91 (https://doi.org/10.1016/s0140-6736(99)06527-7).
Sources
In the knowledge graph
- IRI
references/10665-385385.sec-007.49 - provenance: extracted
- read from
references/10665-385385.sec-007.49.json(who-iris, sub-graph who-iris-references) - derived from
library/10665-385385/sections/sec-007-references.md
-
Rao MR, Naficy AB, Darwish MA, Darwish NM, Schisterman E, Clemens JD et al. Further evidence for association of hepatitis C infection with parenteral schistosomiasis treatment in Egypt. BMC Infect Dis. 2002;2:29 (https://doi.org/10.1186/1471-2334-2-29). PMICD:PMC139974).
· extracted · doi:10.1186/1471-2334-2-29 · source:references/10665-385385.sec-007.50.jsonRao MR, Naficy AB, Darwish MA, Darwish NM, Schisterman E, Clemens JD et al. Further evidence for association of hepatitis C infection with parenteral schistosomiasis treatment in Egypt. BMC Infect Dis. 2002;2:29 (https://doi.org/10.1186/1471-2334-2-29). PMICD:PMC139974).
- Issued
- 2002
- Type
- article-journal
- DOI
- 10.1186/1471-2334-2-29
- As printed
- Rao MR, Naficy AB, Darwish MA, Darwish NM, Schisterman E, Clemens JD et al. Further evidence for association of hepatitis C infection with parenteral schistosomiasis treatment in Egypt. BMC Infect Dis. 2002;2:29 (https://doi.org/10.1186/1471-2334-2-29). PMICD:PMC139974).
Sources
In the knowledge graph
- IRI
references/10665-385385.sec-007.50 - provenance: extracted
- read from
references/10665-385385.sec-007.50.json(who-iris, sub-graph who-iris-references) - derived from
library/10665-385385/sections/sec-007-references.md
-
Alaama AS, Jamil MS, Wilson N, Allegranzi B. Breaking barriers to hepatitis C elimination in the WHO Eastern Mediterranean Region. Lancet Gastroenterol Hepatol. 2025;10(10):874-6 (https://doi.org/10.1016/S2468-1253(25)00240-7).
· extracted · doi:10.1016/S2468-1253(25)00240-7 · source:references/10665-385385.sec-007.51.jsonAlaama AS, Jamil MS, Wilson N, Allegranzi B. Breaking barriers to hepatitis C elimination in the WHO Eastern Mediterranean Region. Lancet Gastroenterol Hepatol. 2025;10(10):874-6 (https://doi.org/10.1016/S2468-1253(25)00240-7).
- Issued
- 2025
- Type
- article-journal
- DOI
- 10.1016/S2468-1253(25)00240-7
- As printed
- Alaama AS, Jamil MS, Wilson N, Allegranzi B. Breaking barriers to hepatitis C elimination in the WHO Eastern Mediterranean Region. Lancet Gastroenterol Hepatol. 2025;10(10):874-6 (https://doi.org/10.1016/S2468-1253(25)00240-7).
Sources
In the knowledge graph
- IRI
references/10665-385385.sec-007.51 - provenance: extracted
- read from
references/10665-385385.sec-007.51.json(who-iris, sub-graph who-iris-references) - derived from
library/10665-385385/sections/sec-007-references.md
-
Global tuberculosis report 2025. Geneva: World Health Organization; 2025 (https://iris.who.int/handle/10665/383364). Licence: CC BY-NC-SA 3.0 IGO.
· extracted · link · source:references/10665-385385.sec-007.52.jsonGlobal tuberculosis report 2025. Geneva: World Health Organization; 2025 (https://iris.who.int/handle/10665/383364). Licence: CC BY-NC-SA 3.0 IGO.
- Issued
- 2025
- Type
- document
- As printed
- Global tuberculosis report 2025. Geneva: World Health Organization; 2025 (https://iris.who.int/handle/10665/383364). Licence: CC BY-NC-SA 3.0 IGO.
Sources
- iris.who.int/handle/10665/383364 (canonical)
In the knowledge graph
- IRI
references/10665-385385.sec-007.52 - provenance: extracted
- read from
references/10665-385385.sec-007.52.json(who-iris, sub-graph who-iris-references) - derived from
library/10665-385385/sections/sec-007-references.md
-
Stockdale AJ, Kreuels B, Henrion MYR, Giorgi E, Kyomuhangi I, de Martel C et al. The global prevalence of hepatitis D virus infection: Systematic review and meta-analysis. J Hepatol. 2020;73(3):523-32 (https://doi.org/10.1016/j.jhep.2020.04.008). PMICD:PMC7438974).
· extracted · doi:10.1016/j.jhep.2020.04.008 · source:references/10665-385385.sec-007.53.jsonStockdale AJ, Kreuels B, Henrion MYR, Giorgi E, Kyomuhangi I, de Martel C et al. The global prevalence of hepatitis D virus infection: Systematic review and meta-analysis. J Hepatol. 2020;73(3):523-32 (https://doi.org/10.1016/j.jhep.2020.04.008). PMICD:PMC7438974).
- Issued
- 2020
- Type
- article-journal
- DOI
- 10.1016/j.jhep.2020.04.008
- As printed
- Stockdale AJ, Kreuels B, Henrion MYR, Giorgi E, Kyomuhangi I, de Martel C et al. The global prevalence of hepatitis D virus infection: Systematic review and meta-analysis. J Hepatol. 2020;73(3):523-32 (https://doi.org/10.1016/j.jhep.2020.04.008). PMICD:PMC7438974).
Sources
In the knowledge graph
- IRI
references/10665-385385.sec-007.53 - provenance: extracted
- read from
references/10665-385385.sec-007.53.json(who-iris, sub-graph who-iris-references) - derived from
library/10665-385385/sections/sec-007-references.md
-
Polaris Observatory Collaborators. Adjusted estimate of the prevalence of hepatitis delta virus in 25 countries and territories. J Hepatol. 2024;80(2):232-42 (https://doi.org/10.1016/j.jhep.2023.10.043).
· extracted · doi:10.1016/j.jhep.2023.10.043 · source:references/10665-385385.sec-007.54.jsonPolaris Observatory Collaborators. Adjusted estimate of the prevalence of hepatitis delta virus in 25 countries and territories. J Hepatol. 2024;80(2):232-42 (https://doi.org/10.1016/j.jhep.2023.10.043).
- Issued
- 2024
- Type
- article-journal
- DOI
- 10.1016/j.jhep.2023.10.043
- As printed
- Polaris Observatory Collaborators. Adjusted estimate of the prevalence of hepatitis delta virus in 25 countries and territories. J Hepatol. 2024;80(2):232-42 (https://doi.org/10.1016/j.jhep.2023.10.043).
Sources
In the knowledge graph
- IRI
references/10665-385385.sec-007.54 - provenance: extracted
- read from
references/10665-385385.sec-007.54.json(who-iris, sub-graph who-iris-references) - derived from
library/10665-385385/sections/sec-007-references.md
-
World Health Organization. Hepatitis B vaccines: WHO position paper - recommendations. Vaccine. 2010;28(3):589-90 (https://doi.org/10.1016/j.vaccine.2009.10.110).
· extracted · doi:10.1016/j.vaccine.2009.10.110 · source:references/10665-385385.sec-007.55.jsonWorld Health Organization. Hepatitis B vaccines: WHO position paper - recommendations. Vaccine. 2010;28(3):589-90 (https://doi.org/10.1016/j.vaccine.2009.10.110).
- Issued
- 2010
- Type
- article-journal
- DOI
- 10.1016/j.vaccine.2009.10.110
- As printed
- World Health Organization. Hepatitis B vaccines: WHO position paper - recommendations. Vaccine. 2010;28(3):589-90 (https://doi.org/10.1016/j.vaccine.2009.10.110).
Sources
In the knowledge graph
- IRI
references/10665-385385.sec-007.55 - provenance: extracted
- read from
references/10665-385385.sec-007.55.json(who-iris, sub-graph who-iris-references) - derived from
library/10665-385385/sections/sec-007-references.md
-
Hepatitis B vaccination policies, practices and challenges to achieving hepatitis elimination in the European Union and European Economic Area. Stockholm: European Centre for Disease Prevention and Control; 2025 (https://www.ecdc.europa.eu/en/publications-data/hepatitis-b-vaccination-policies-practices-and-challenges-achieving-hepatitis).
· extracted · link · source:references/10665-385385.sec-007.56.jsonHepatitis B vaccination policies, practices and challenges to achieving hepatitis elimination in the European Union and European Economic Area. Stockholm: European Centre for Disease Prevention and Control; 2025 (https://www.ecdc.europa.eu/en/publications-data/hepatitis-b-vaccination-policies-practices-and-challenges-achieving-hepatitis).
- Issued
- 2025
- Type
- document
- As printed
- Hepatitis B vaccination policies, practices and challenges to achieving hepatitis elimination in the European Union and European Economic Area. Stockholm: European Centre for Disease Prevention and Control; 2025 (https://www.ecdc.europa.eu/en/publications-data/hepatitis-b-vaccination-policies-practices-and-challenges-achieving-hepatitis).
Sources
In the knowledge graph
- IRI
references/10665-385385.sec-007.56 - provenance: extracted
- read from
references/10665-385385.sec-007.56.json(who-iris, sub-graph who-iris-references) - derived from
library/10665-385385/sections/sec-007-references.md
-
Chaudhary RK. Perinatal transmission of hepatitis B virus. Can Med Assoc J. 1983;128(6):664-6 (PMICD: PMC1875192, https://pubmed.ncbi.nlm.nih.gov/6825030/).
· extracted · link · source:references/10665-385385.sec-007.57.jsonChaudhary RK. Perinatal transmission of hepatitis B virus. Can Med Assoc J. 1983;128(6):664-6 (PMICD: PMC1875192, https://pubmed.ncbi.nlm.nih.gov/6825030/).
- Issued
- 1983
- Type
- article-journal
- As printed
- Chaudhary RK. Perinatal transmission of hepatitis B virus. Can Med Assoc J. 1983;128(6):664-6 (PMICD: PMC1875192, https://pubmed.ncbi.nlm.nih.gov/6825030/).
Sources
- pubmed.ncbi.nlm.nih.gov/6825030/ (canonical)
In the knowledge graph
- IRI
references/10665-385385.sec-007.57 - provenance: extracted
- read from
references/10665-385385.sec-007.57.json(who-iris, sub-graph who-iris-references) - derived from
library/10665-385385/sections/sec-007-references.md
-
Keane E, Funk AL, Shimakawa Y. Systematic review with meta-analysis: the risk of mother-to-child transmission of hepatitis B virus infection in sub-Saharan Africa. Aliment Pharmacol Ther. 2016;44(10):1005-17 (https://doi.org/10.1111/apt.13795).
· extracted · doi:10.1111/apt.13795 · source:references/10665-385385.sec-007.58.jsonKeane E, Funk AL, Shimakawa Y. Systematic review with meta-analysis: the risk of mother-to-child transmission of hepatitis B virus infection in sub-Saharan Africa. Aliment Pharmacol Ther. 2016;44(10):1005-17 (https://doi.org/10.1111/apt.13795).
- Issued
- 2016
- Type
- article-journal
- DOI
- 10.1111/apt.13795
- As printed
- Keane E, Funk AL, Shimakawa Y. Systematic review with meta-analysis: the risk of mother-to-child transmission of hepatitis B virus infection in sub-Saharan Africa. Aliment Pharmacol Ther. 2016;44(10):1005-17 (https://doi.org/10.1111/apt.13795).
Sources
- doi:10.1111/apt.13795 (doi)
In the knowledge graph
- IRI
references/10665-385385.sec-007.58 - provenance: extracted
- read from
references/10665-385385.sec-007.58.json(who-iris, sub-graph who-iris-references) - derived from
library/10665-385385/sections/sec-007-references.md
-
Beasley RP, Trepo C, Stevens CE, Szmuness W. The e antigen and vertical transmission of hepatitis B surface antigen. Am J Epidemiol. 1977;105(2):94-8 (https://doi.org/10.1093/oxfordjournals.aje.a112370).
· extracted · doi:10.1093/oxfordjournals.aje.a112370 · source:references/10665-385385.sec-007.59.jsonBeasley RP, Trepo C, Stevens CE, Szmuness W. The e antigen and vertical transmission of hepatitis B surface antigen. Am J Epidemiol. 1977;105(2):94-8 (https://doi.org/10.1093/oxfordjournals.aje.a112370).
- Issued
- 1977
- Type
- article-journal
- DOI
- 10.1093/oxfordjournals.aje.a112370
- As printed
- Beasley RP, Trepo C, Stevens CE, Szmuness W. The e antigen and vertical transmission of hepatitis B surface antigen. Am J Epidemiol. 1977;105(2):94-8 (https://doi.org/10.1093/oxfordjournals.aje.a112370).
Sources
In the knowledge graph
- IRI
references/10665-385385.sec-007.59 - provenance: extracted
- read from
references/10665-385385.sec-007.59.json(who-iris, sub-graph who-iris-references) - derived from
library/10665-385385/sections/sec-007-references.md
-
Okada K, Kamiyama I, Inomata M, Imai M, Miyakawa Y, Mayumi M. e antigen and anti-e in the serum of asymptomatic carrier mothers as indicators of positive and negative transmission of hepatitis B virus to their infants. N Engl J Med. 1976;294(14):746-9 (https://doi.org/10.1056/NEJM197604012941402).
· extracted · doi:10.1056/NEJM197604012941402 · source:references/10665-385385.sec-007.60.jsonOkada K, Kamiyama I, Inomata M, Imai M, Miyakawa Y, Mayumi M. e antigen and anti-e in the serum of asymptomatic carrier mothers as indicators of positive and negative transmission of hepatitis B virus to their infants. N Engl J Med. 1976;294(14):746-9 (https://doi.org/10.1056/NEJM197604012941402).
- Issued
- 1976
- Type
- article-journal
- DOI
- 10.1056/NEJM197604012941402
- As printed
- Okada K, Kamiyama I, Inomata M, Imai M, Miyakawa Y, Mayumi M. e antigen and anti-e in the serum of asymptomatic carrier mothers as indicators of positive and negative transmission of hepatitis B virus to their infants. N Engl J Med. 1976;294(14):746-9 (https://doi.org/10.1056/NEJM197604012941402).
Sources
In the knowledge graph
- IRI
references/10665-385385.sec-007.60 - provenance: extracted
- read from
references/10665-385385.sec-007.60.json(who-iris, sub-graph who-iris-references) - derived from
library/10665-385385/sections/sec-007-references.md
-
Shimakawa Y, Bottomley C, Njie R, Mendy M. The association between maternal hepatitis B e antigen status, as a proxy for perinatal transmission, and the risk of hepatitis B e antigenaemia in Gambian children. BMC Public Health. 2014;14:532 (https://doi.org/10.1186/1471-2458-14-532). PMICD:PMC4066313).
· extracted · doi:10.1186/1471-2458-14-532 · source:references/10665-385385.sec-007.61.jsonShimakawa Y, Bottomley C, Njie R, Mendy M. The association between maternal hepatitis B e antigen status, as a proxy for perinatal transmission, and the risk of hepatitis B e antigenaemia in Gambian children. BMC Public Health. 2014;14:532 (https://doi.org/10.1186/1471-2458-14-532). PMICD:PMC4066313).
- Issued
- 2014
- Type
- article-journal
- DOI
- 10.1186/1471-2458-14-532
- As printed
- Shimakawa Y, Bottomley C, Njie R, Mendy M. The association between maternal hepatitis B e antigen status, as a proxy for perinatal transmission, and the risk of hepatitis B e antigenaemia in Gambian children. BMC Public Health. 2014;14:532 (https://doi.org/10.1186/1471-2458-14-532). PMICD:PMC4066313).
Sources
In the knowledge graph
- IRI
references/10665-385385.sec-007.61 - provenance: extracted
- read from
references/10665-385385.sec-007.61.json(who-iris, sub-graph who-iris-references) - derived from
library/10665-385385/sections/sec-007-references.md
-
Brown RS, Jr., McMahon BJ, Lok ASF, Wong JB, Ahmed AT, Mouchli MA et al. Antiviral therapy in chronic hepatitis B viral infection during pregnancy: A systematic review and meta-analysis. Hepatology. 2016;63(1):319-33 (https://doi.org/10.1002/hep.28302).
· extracted · doi:10.1002/hep.28302 · source:references/10665-385385.sec-007.62.jsonBrown RS, Jr., McMahon BJ, Lok ASF, Wong JB, Ahmed AT, Mouchli MA et al. Antiviral therapy in chronic hepatitis B viral infection during pregnancy: A systematic review and meta-analysis. Hepatology. 2016;63(1):319-33 (https://doi.org/10.1002/hep.28302).
- Issued
- 2016
- Type
- article-journal
- DOI
- 10.1002/hep.28302
- As printed
- Brown RS, Jr., McMahon BJ, Lok ASF, Wong JB, Ahmed AT, Mouchli MA et al. Antiviral therapy in chronic hepatitis B viral infection during pregnancy: A systematic review and meta-analysis. Hepatology. 2016;63(1):319-33 (https://doi.org/10.1002/hep.28302).
Sources
- doi:10.1002/hep.28302 (doi)
In the knowledge graph
- IRI
references/10665-385385.sec-007.62 - provenance: extracted
- read from
references/10665-385385.sec-007.62.json(who-iris, sub-graph who-iris-references) - derived from
library/10665-385385/sections/sec-007-references.md
-
Machaira M, Papaevangelou V, Vouloumanou EK, Tansarli GS, Falagas ME. Hepatitis B vaccine alone or with hepatitis B immunoglobulin in neonates of HBsAg+/HBeAg- mothers: a systematic review and meta-analysis. J Antimicrob Chemother. 2015;70(2):396-404 (https://doi.org/10.1093/jac/dku404).
· extracted · doi:10.1093/jac/dku404 · source:references/10665-385385.sec-007.63.jsonMachaira M, Papaevangelou V, Vouloumanou EK, Tansarli GS, Falagas ME. Hepatitis B vaccine alone or with hepatitis B immunoglobulin in neonates of HBsAg+/HBeAg- mothers: a systematic review and meta-analysis. J Antimicrob Chemother. 2015;70(2):396-404 (https://doi.org/10.1093/jac/dku404).
- Issued
- 2015
- Type
- article-journal
- DOI
- 10.1093/jac/dku404
- As printed
- Machaira M, Papaevangelou V, Vouloumanou EK, Tansarli GS, Falagas ME. Hepatitis B vaccine alone or with hepatitis B immunoglobulin in neonates of HBsAg+/HBeAg- mothers: a systematic review and meta-analysis. J Antimicrob Chemother. 2015;70(2):396-404 (https://doi.org/10.1093/jac/dku404).
Sources
- doi:10.1093/jac/dku404 (doi)
In the knowledge graph
- IRI
references/10665-385385.sec-007.63 - provenance: extracted
- read from
references/10665-385385.sec-007.63.json(who-iris, sub-graph who-iris-references) - derived from
library/10665-385385/sections/sec-007-references.md
-
Lee C, Gong Y, Brok J, Boxall EH, Gluud C. Hepatitis B immunisation for newborn infants of hepatitis B surface antigen-positive mothers. Cochrane Database Syst Rev. 2006(2):Cd004790 (https://doi.org/10.1002/14651858.CD004790.pub2).
· extracted · doi:10.1002/14651858.CD004790.pub2 · source:references/10665-385385.sec-007.64.jsonLee C, Gong Y, Brok J, Boxall EH, Gluud C. Hepatitis B immunisation for newborn infants of hepatitis B surface antigen-positive mothers. Cochrane Database Syst Rev. 2006(2):Cd004790 (https://doi.org/10.1002/14651858.CD004790.pub2).
- Issued
- 2006
- Type
- document
- DOI
- 10.1002/14651858.CD004790.pub2
- As printed
- Lee C, Gong Y, Brok J, Boxall EH, Gluud C. Hepatitis B immunisation for newborn infants of hepatitis B surface antigen-positive mothers. Cochrane Database Syst Rev. 2006(2):Cd004790 (https://doi.org/10.1002/14651858.CD004790.pub2).
Sources
In the knowledge graph
- IRI
references/10665-385385.sec-007.64 - provenance: extracted
- read from
references/10665-385385.sec-007.64.json(who-iris, sub-graph who-iris-references) - derived from
library/10665-385385/sections/sec-007-references.md
-
Operational Data Portal: Bangladesh. [website]. UN Refugee Agency; (https://data.unhcr.org/en/country/bgd).
· extracted · link · source:references/10665-385385.sec-007.65.jsonOperational Data Portal: Bangladesh. [website]. UN Refugee Agency; (https://data.unhcr.org/en/country/bgd).
- Type
- document
- As printed
- Operational Data Portal: Bangladesh. [website]. UN Refugee Agency; (https://data.unhcr.org/en/country/bgd).
Sources
- data.unhcr.org/en/country/bgd (canonical)
In the knowledge graph
- IRI
references/10665-385385.sec-007.65 - provenance: extracted
- read from
references/10665-385385.sec-007.65.json(who-iris, sub-graph who-iris-references) - derived from
library/10665-385385/sections/sec-007-references.md
-
Samarasekera U. Hepatitis C epidemic among Rohingya refugees in Cox's Bazar: a public health emergency. The Lancet Gastroenterology & Hepatology. 2024;9(9):789 (https://doi.org/10.1016/S2468-1253(24)00230-9).
· extracted · doi:10.1016/S2468-1253(24)00230-9 · source:references/10665-385385.sec-007.66.jsonSamarasekera U. Hepatitis C epidemic among Rohingya refugees in Cox's Bazar: a public health emergency. The Lancet Gastroenterology & Hepatology. 2024;9(9):789 (https://doi.org/10.1016/S2468-1253(24)00230-9).
- Issued
- 2024
- Type
- article-journal
- DOI
- 10.1016/S2468-1253(24)00230-9
- As printed
- Samarasekera U. Hepatitis C epidemic among Rohingya refugees in Cox's Bazar: a public health emergency. The Lancet Gastroenterology & Hepatology. 2024;9(9):789 (https://doi.org/10.1016/S2468-1253(24)00230-9).
Sources
In the knowledge graph
- IRI
references/10665-385385.sec-007.66 - provenance: extracted
- read from
references/10665-385385.sec-007.66.json(who-iris, sub-graph who-iris-references) - derived from
library/10665-385385/sections/sec-007-references.md
-
Guidelines for the screening, care and treatment of persons with hepatitis C infection. Geneva: World Health Organization; 2014 (https://iris.who.int/handle/10665/111747). Licence: CC BY-NC-SA 3.0 IGO. 74 | Global hepatitis report 2026
· extracted · link · source:references/10665-385385.sec-007.67.jsonGuidelines for the screening, care and treatment of persons with hepatitis C infection. Geneva: World Health Organization; 2014 (https://iris.who.int/handle/10665/111747). Licence: CC BY-NC-SA 3.0 IGO. 74 | Global hepatitis report 2026
- Issued
- 2026
- Type
- document
- As printed
- Guidelines for the screening, care and treatment of persons with hepatitis C infection. Geneva: World Health Organization; 2014 (https://iris.who.int/handle/10665/111747). Licence: CC BY-NC-SA 3.0 IGO. 74 | Global hepatitis report 2026
Sources
- iris.who.int/handle/10665/111747 (canonical)
In the knowledge graph
- IRI
references/10665-385385.sec-007.67 - provenance: extracted
- read from
references/10665-385385.sec-007.67.json(who-iris, sub-graph who-iris-references) - derived from
library/10665-385385/sections/sec-007-references.md
-
Estes C, Abdel-Kareem M, Abdel-Razek W, Abdel-Sameea E, Abuzeid M, Gomaa A et al. Economic burden of hepatitis C in Egypt: the future impact of highly effective therapies. Aliment Pharmacol Ther. 2015;42(6):696-706 (https://doi.org/10.1111/apt.13316). PMICD:PMC5034818).
· extracted · doi:10.1111/apt.13316 · source:references/10665-385385.sec-007.68.jsonEstes C, Abdel-Kareem M, Abdel-Razek W, Abdel-Sameea E, Abuzeid M, Gomaa A et al. Economic burden of hepatitis C in Egypt: the future impact of highly effective therapies. Aliment Pharmacol Ther. 2015;42(6):696-706 (https://doi.org/10.1111/apt.13316). PMICD:PMC5034818).
- Issued
- 2015
- Type
- article-journal
- DOI
- 10.1111/apt.13316
- As printed
- Estes C, Abdel-Kareem M, Abdel-Razek W, Abdel-Sameea E, Abuzeid M, Gomaa A et al. Economic burden of hepatitis C in Egypt: the future impact of highly effective therapies. Aliment Pharmacol Ther. 2015;42(6):696-706 (https://doi.org/10.1111/apt.13316). PMICD:PMC5034818).
Sources
- doi:10.1111/apt.13316 (doi)
In the knowledge graph
- IRI
references/10665-385385.sec-007.68 - provenance: extracted
- read from
references/10665-385385.sec-007.68.json(who-iris, sub-graph who-iris-references) - derived from
library/10665-385385/sections/sec-007-references.md
-
Screening donated blood for transfusion‑transmissible infections: recommendations. Geneva: World Health Organization; 2009 (https://iris.who.int/handle/10665/44202). Licence: CC BY-NC-SA 3.0 IGO.
· extracted · link · source:references/10665-385385.sec-007.69.jsonScreening donated blood for transfusion‑transmissible infections: recommendations. Geneva: World Health Organization; 2009 (https://iris.who.int/handle/10665/44202). Licence: CC BY-NC-SA 3.0 IGO.
- Issued
- 2009
- Type
- document
- As printed
- Screening donated blood for transfusion‑transmissible infections: recommendations. Geneva: World Health Organization; 2009 (https://iris.who.int/handle/10665/44202). Licence: CC BY-NC-SA 3.0 IGO.
Sources
- iris.who.int/handle/10665/44202 (canonical)
In the knowledge graph
- IRI
references/10665-385385.sec-007.69 - provenance: extracted
- read from
references/10665-385385.sec-007.69.json(who-iris, sub-graph who-iris-references) - derived from
library/10665-385385/sections/sec-007-references.md
-
Action framework to advance universal access to safe, effective and quality-assured blood products 2020–2023. World Health Organization; 2020 (https://iris.who.int/handle/10665/331002). Licence: CC BY-NC-SA 3.0 IGO.
· extracted · link · source:references/10665-385385.sec-007.70.jsonAction framework to advance universal access to safe, effective and quality-assured blood products 2020–2023. World Health Organization; 2020 (https://iris.who.int/handle/10665/331002). Licence: CC BY-NC-SA 3.0 IGO.
- Issued
- 2020
- Type
- document
- As printed
- Action framework to advance universal access to safe, effective and quality-assured blood products 2020–2023. World Health Organization; 2020 (https://iris.who.int/handle/10665/331002). Licence: CC BY-NC-SA 3.0 IGO.
Sources
- iris.who.int/handle/10665/331002 (canonical)
In the knowledge graph
- IRI
references/10665-385385.sec-007.70 - provenance: extracted
- read from
references/10665-385385.sec-007.70.json(who-iris, sub-graph who-iris-references) - derived from
library/10665-385385/sections/sec-007-references.md
-
Global status report on blood safety and availability 2021. Geneva: World Health Organization; 2021 (https://iris.who.int/handle/10665/356165). Licence: CC BY-NCSA 3.0 IGO.
· extracted · link · source:references/10665-385385.sec-007.71.jsonGlobal status report on blood safety and availability 2021. Geneva: World Health Organization; 2021 (https://iris.who.int/handle/10665/356165). Licence: CC BY-NCSA 3.0 IGO.
- Issued
- 2021
- Type
- document
- As printed
- Global status report on blood safety and availability 2021. Geneva: World Health Organization; 2021 (https://iris.who.int/handle/10665/356165). Licence: CC BY-NCSA 3.0 IGO.
Sources
- iris.who.int/handle/10665/356165 (canonical)
In the knowledge graph
- IRI
references/10665-385385.sec-007.71 - provenance: extracted
- read from
references/10665-385385.sec-007.71.json(who-iris, sub-graph who-iris-references) - derived from
library/10665-385385/sections/sec-007-references.md
-
Candotti D, Boizeau L, Laperche S. Occult hepatitis B infection and transfusion-transmission risk. Transfus Clin Biol. 2017;24(3):189-95 (https://doi.org/10.1016/j.tracli.2017.06.014).
· extracted · doi:10.1016/j.tracli.2017.06.014 · source:references/10665-385385.sec-007.72.jsonCandotti D, Boizeau L, Laperche S. Occult hepatitis B infection and transfusion-transmission risk. Transfus Clin Biol. 2017;24(3):189-95 (https://doi.org/10.1016/j.tracli.2017.06.014).
- Issued
- 2017
- Type
- article-journal
- DOI
- 10.1016/j.tracli.2017.06.014
- As printed
- Candotti D, Boizeau L, Laperche S. Occult hepatitis B infection and transfusion-transmission risk. Transfus Clin Biol. 2017;24(3):189-95 (https://doi.org/10.1016/j.tracli.2017.06.014).
Sources
In the knowledge graph
- IRI
references/10665-385385.sec-007.72 - provenance: extracted
- read from
references/10665-385385.sec-007.72.json(who-iris, sub-graph who-iris-references) - derived from
library/10665-385385/sections/sec-007-references.md
-
Busch MP, Bloch EM, Kleinman S. Prevention of transfusion-transmitted infections. Blood. 2019;133(17):1854-64 (https://doi.org/10.1182/blood-2018-11-833996).
· extracted · doi:10.1182/blood-2018-11-833996 · source:references/10665-385385.sec-007.73.jsonBusch MP, Bloch EM, Kleinman S. Prevention of transfusion-transmitted infections. Blood. 2019;133(17):1854-64 (https://doi.org/10.1182/blood-2018-11-833996).
- Issued
- 2019
- Type
- article-journal
- DOI
- 10.1182/blood-2018-11-833996
- As printed
- Busch MP, Bloch EM, Kleinman S. Prevention of transfusion-transmitted infections. Blood. 2019;133(17):1854-64 (https://doi.org/10.1182/blood-2018-11-833996).
Sources
In the knowledge graph
- IRI
references/10665-385385.sec-007.73 - provenance: extracted
- read from
references/10665-385385.sec-007.73.json(who-iris, sub-graph who-iris-references) - derived from
library/10665-385385/sections/sec-007-references.md
-
Rapiti E, Dhingra N, Hutin Y, Lloyd S. The global burden of HBV and HCV infection attributable to unsafe blood transfusions (poster). In: 11th International Symposium on Viral Hepatitis and Liver Disease. Sydney, Australia; 2003.
· extracted · source:references/10665-385385.sec-007.74.jsonRapiti E, Dhingra N, Hutin Y, Lloyd S. The global burden of HBV and HCV infection attributable to unsafe blood transfusions (poster). In: 11th International Symposium on Viral Hepatitis and Liver Disease. Sydney, Australia; 2003.
- Issued
- 2003
- Type
- document
- As printed
- Rapiti E, Dhingra N, Hutin Y, Lloyd S. The global burden of HBV and HCV infection attributable to unsafe blood transfusions (poster). In: 11th International Symposium on Viral Hepatitis and Liver Disease. Sydney, Australia; 2003.
Sources
No link to the work is recorded for this reference.
In the knowledge graph
- IRI
references/10665-385385.sec-007.74 - provenance: extracted
- read from
references/10665-385385.sec-007.74.json(who-iris, sub-graph who-iris-references) - derived from
library/10665-385385/sections/sec-007-references.md
-
Ahmed Kiani R, Anwar M, Waheed U, Asad MJ, Abbasi S, Abbas Zaheer H. Epidemiology of Transfusion Transmitted Infection among Patients with β‐Thalassaemia Major in Pakistan. Journal of blood transfusion. 2016;2016(1):8135649 (https://doi.org/10.1155/2016/8135649).
· extracted · doi:10.1155/2016/8135649 · source:references/10665-385385.sec-007.75.jsonAhmed Kiani R, Anwar M, Waheed U, Asad MJ, Abbasi S, Abbas Zaheer H. Epidemiology of Transfusion Transmitted Infection among Patients with β‐Thalassaemia Major in Pakistan. Journal of blood transfusion. 2016;2016(1):8135649 (https://doi.org/10.1155/2016/8135649).
- Issued
- 2016
- Type
- article-journal
- DOI
- 10.1155/2016/8135649
- As printed
- Ahmed Kiani R, Anwar M, Waheed U, Asad MJ, Abbasi S, Abbas Zaheer H. Epidemiology of Transfusion Transmitted Infection among Patients with β‐Thalassaemia Major in Pakistan. Journal of blood transfusion. 2016;2016(1):8135649 (https://doi.org/10.1155/2016/8135649).
Sources
- doi:10.1155/2016/8135649 (doi)
In the knowledge graph
- IRI
references/10665-385385.sec-007.75 - provenance: extracted
- read from
references/10665-385385.sec-007.75.json(who-iris, sub-graph who-iris-references) - derived from
library/10665-385385/sections/sec-007-references.md
-
Tagny CT, Owusu‐Ofori S, Mbanya D, Deneys V. The blood donor in sub‐Saharan Africa: a review. Transfus Med. 2010;20(1):1-10 (https://doi.org/10.1111/j.1365-3148.2009.00958.x).
· extracted · doi:10.1111/j.1365-3148.2009.00958.x · source:references/10665-385385.sec-007.76.jsonTagny CT, Owusu‐Ofori S, Mbanya D, Deneys V. The blood donor in sub‐Saharan Africa: a review. Transfus Med. 2010;20(1):1-10 (https://doi.org/10.1111/j.1365-3148.2009.00958.x).
- Issued
- 2010
- Type
- article-journal
- DOI
- 10.1111/j.1365-3148.2009.00958.x
- As printed
- Tagny CT, Owusu‐Ofori S, Mbanya D, Deneys V. The blood donor in sub‐Saharan Africa: a review. Transfus Med. 2010;20(1):1-10 (https://doi.org/10.1111/j.1365-3148.2009.00958.x).
Sources
In the knowledge graph
- IRI
references/10665-385385.sec-007.76 - provenance: extracted
- read from
references/10665-385385.sec-007.76.json(who-iris, sub-graph who-iris-references) - derived from
library/10665-385385/sections/sec-007-references.md
-
World Bank country and lending groups [website]. World Bank; 2026 (https://datahelpdesk.worldbank.org/knowledgebase/articles/906519-world-bank-country-and-lending-groups).
· extracted · link · source:references/10665-385385.sec-007.77.jsonWorld Bank country and lending groups [website]. World Bank; 2026 (https://datahelpdesk.worldbank.org/knowledgebase/articles/906519-world-bank-country-and-lending-groups).
- Issued
- 2026
- Type
- document
- As printed
- World Bank country and lending groups [website]. World Bank; 2026 (https://datahelpdesk.worldbank.org/knowledgebase/articles/906519-world-bank-country-and-lending-groups).
Sources
- datahelpdesk.worldbank.org/knowledgebase/articles/906519-world-bank-country-and-lending-groups (canonical)
In the knowledge graph
- IRI
references/10665-385385.sec-007.77 - provenance: extracted
- read from
references/10665-385385.sec-007.77.json(who-iris, sub-graph who-iris-references) - derived from
library/10665-385385/sections/sec-007-references.md
-
Make smart injection choices: safe injection practices (pamphlet). Geneva: World Health Organization; 2017 (https://cdn.who.int/media/docs/default-source/integrated-health-services-(ihs)/infection-prevention-and-control/injection-safety/advocacy/is_healthcareproviders_leaflet.pdf). Licence: CC BY-NC-SA 3.0 IGO.
· extracted · link · source:references/10665-385385.sec-007.78.jsonMake smart injection choices: safe injection practices (pamphlet). Geneva: World Health Organization; 2017 (https://cdn.who.int/media/docs/default-source/integrated-health-services-(ihs)/infection-prevention-and-control/injection-safety/advocacy/is_healthcareproviders_leaflet.pdf). Licence: CC BY-NC-SA 3.0 IGO.
- Issued
- 2017
- Type
- document
- As printed
- Make smart injection choices: safe injection practices (pamphlet). Geneva: World Health Organization; 2017 (https://cdn.who.int/media/docs/default-source/integrated-health-services-(ihs)/infection-prevention-and-control/injection-safety/advocacy/is_healthcareproviders_leaflet.pdf). Licence: CC BY-NC-SA 3.0 IGO.
Sources
In the knowledge graph
- IRI
references/10665-385385.sec-007.78 - provenance: extracted
- read from
references/10665-385385.sec-007.78.json(who-iris, sub-graph who-iris-references) - derived from
library/10665-385385/sections/sec-007-references.md
-
WHO guideline on the use of safety-engineered syringes for intramuscular, intradermal and subcutaneous injections in health care settings. Geneva: World Health Organization; 2016 (https://iris.who.int/handle/10665/250144). Licence: 9789241549820.
· extracted · link · source:references/10665-385385.sec-007.79.jsonWHO guideline on the use of safety-engineered syringes for intramuscular, intradermal and subcutaneous injections in health care settings. Geneva: World Health Organization; 2016 (https://iris.who.int/handle/10665/250144). Licence: 9789241549820.
- Issued
- 2016
- Type
- document
- As printed
- WHO guideline on the use of safety-engineered syringes for intramuscular, intradermal and subcutaneous injections in health care settings. Geneva: World Health Organization; 2016 (https://iris.who.int/handle/10665/250144). Licence: 9789241549820.
Sources
- iris.who.int/handle/10665/250144 (canonical)
In the knowledge graph
- IRI
references/10665-385385.sec-007.79 - provenance: extracted
- read from
references/10665-385385.sec-007.79.json(who-iris, sub-graph who-iris-references) - derived from
library/10665-385385/sections/sec-007-references.md
-
Hayashi T, Hutin YJ-F, Bulterys M, Altaf A, Allegranzi B. Injection practices in 2011–2015: a review using data from the demographic and health surveys (DHS). BMC health services research. 2019;19(1):600 (https://doi.org/10.1186/s12913-019-4366-9).
· extracted · doi:10.1186/s12913-019-4366-9 · source:references/10665-385385.sec-007.80.jsonHayashi T, Hutin YJ-F, Bulterys M, Altaf A, Allegranzi B. Injection practices in 2011–2015: a review using data from the demographic and health surveys (DHS). BMC health services research. 2019;19(1):600 (https://doi.org/10.1186/s12913-019-4366-9).
- Issued
- 2019
- Type
- article-journal
- DOI
- 10.1186/s12913-019-4366-9
- As printed
- Hayashi T, Hutin YJ-F, Bulterys M, Altaf A, Allegranzi B. Injection practices in 2011–2015: a review using data from the demographic and health surveys (DHS). BMC health services research. 2019;19(1):600 (https://doi.org/10.1186/s12913-019-4366-9).
Sources
In the knowledge graph
- IRI
references/10665-385385.sec-007.80 - provenance: extracted
- read from
references/10665-385385.sec-007.80.json(who-iris, sub-graph who-iris-references) - derived from
library/10665-385385/sections/sec-007-references.md
-
Global action plan and monitoring framework on infection prevention and control (IPC), 2024–2030. Geneva: World Health Organization; 2024 (https://www.who.int/teams/integrated-health-services/infection-prevention-control/draft-global-action-plan-and-monitoring-framework-on-ipc#cms). Licence: CC BY-NC-SA 3.0 IGO.
· extracted · link · source:references/10665-385385.sec-007.81.jsonGlobal action plan and monitoring framework on infection prevention and control (IPC), 2024–2030. Geneva: World Health Organization; 2024 (https://www.who.int/teams/integrated-health-services/infection-prevention-control/draft-global-action-plan-and-monitoring-framework-on-ipc#cms). Licence: CC BY-NC-SA 3.0 IGO.
- Issued
- 2024
- Type
- document
- As printed
- Global action plan and monitoring framework on infection prevention and control (IPC), 2024–2030. Geneva: World Health Organization; 2024 (https://www.who.int/teams/integrated-health-services/infection-prevention-control/draft-global-action-plan-and-monitoring-framework-on-ipc#cms). Licence: CC BY-NC-SA 3.0 IGO.
Sources
In the knowledge graph
- IRI
references/10665-385385.sec-007.81 - provenance: extracted
- read from
references/10665-385385.sec-007.81.json(who-iris, sub-graph who-iris-references) - derived from
library/10665-385385/sections/sec-007-references.md
-
Global report on infection prevention and control 2024. Geneva: World Health Organization; 2024 (https://iris.who.int/handle/10665/379632). Licence: CC BY-NC-SA 3.0 IGO.
· extracted · link · source:references/10665-385385.sec-007.82.jsonGlobal report on infection prevention and control 2024. Geneva: World Health Organization; 2024 (https://iris.who.int/handle/10665/379632). Licence: CC BY-NC-SA 3.0 IGO.
- Issued
- 2024
- Type
- document
- As printed
- Global report on infection prevention and control 2024. Geneva: World Health Organization; 2024 (https://iris.who.int/handle/10665/379632). Licence: CC BY-NC-SA 3.0 IGO.
Sources
- iris.who.int/handle/10665/379632 (canonical)
In the knowledge graph
- IRI
references/10665-385385.sec-007.82 - provenance: extracted
- read from
references/10665-385385.sec-007.82.json(who-iris, sub-graph who-iris-references) - derived from
library/10665-385385/sections/sec-007-references.md
-
The global state of harm reduction 2024 (9th edition). London: Harm Reduction International; 2024 (https://hri.global/flagship-research/the-global-state-of-harm-reduction/the-global-state-of-harm-reduction-2024/).
· extracted · link · source:references/10665-385385.sec-007.83.jsonThe global state of harm reduction 2024 (9th edition). London: Harm Reduction International; 2024 (https://hri.global/flagship-research/the-global-state-of-harm-reduction/the-global-state-of-harm-reduction-2024/).
- Issued
- 2024
- Type
- document
- As printed
- The global state of harm reduction 2024 (9th edition). London: Harm Reduction International; 2024 (https://hri.global/flagship-research/the-global-state-of-harm-reduction/the-global-state-of-harm-reduction-2024/).
Sources
- hri.global/flagship-research/the-global-state-of-harm-reduction/the-global-state-of-harm-reduction-2024/ (canonical)
In the knowledge graph
- IRI
references/10665-385385.sec-007.83 - provenance: extracted
- read from
references/10665-385385.sec-007.83.json(who-iris, sub-graph who-iris-references) - derived from
library/10665-385385/sections/sec-007-references.md
-
Clinical descriptions and diagnostic requirements for ICD-11 mental, behavioural and neurodevelopmental disorders. Geneva: World Health Organization; 2024 (https://iris.who.int/handle/10665/375767.). Licence: CC
· extracted · link · source:references/10665-385385.sec-007.84.jsonClinical descriptions and diagnostic requirements for ICD-11 mental, behavioural and neurodevelopmental disorders. Geneva: World Health Organization; 2024 (https://iris.who.int/handle/10665/375767.). Licence: CC
- Issued
- 2024
- Type
- document
- As printed
- Clinical descriptions and diagnostic requirements for ICD-11 mental, behavioural and neurodevelopmental disorders. Geneva: World Health Organization; 2024 (https://iris.who.int/handle/10665/375767.). Licence: CC
Sources
- iris.who.int/handle/10665/375767 (canonical)
In the knowledge graph
- IRI
references/10665-385385.sec-007.84 - provenance: extracted
- read from
references/10665-385385.sec-007.84.json(who-iris, sub-graph who-iris-references) - derived from
library/10665-385385/sections/sec-007-references.md
-
Guidelines for the psychosocially assisted pharmacological treatment of opioid dependence. World Health Organization. Geneva: World Health Organization; 2009 (https://iris.who.int/handle/10665/43948). Licence: CC
· extracted · link · source:references/10665-385385.sec-007.85.jsonGuidelines for the psychosocially assisted pharmacological treatment of opioid dependence. World Health Organization. Geneva: World Health Organization; 2009 (https://iris.who.int/handle/10665/43948). Licence: CC
- Issued
- 2009
- Type
- document
- As printed
- Guidelines for the psychosocially assisted pharmacological treatment of opioid dependence. World Health Organization. Geneva: World Health Organization; 2009 (https://iris.who.int/handle/10665/43948). Licence: CC
Sources
- iris.who.int/handle/10665/43948 (canonical)
In the knowledge graph
- IRI
references/10665-385385.sec-007.85 - provenance: extracted
- read from
references/10665-385385.sec-007.85.json(who-iris, sub-graph who-iris-references) - derived from
library/10665-385385/sections/sec-007-references.md
-
World Drug Report 2025 [website]. United Nations Office on Drugs and Crime; 2025 (https://www.unodc.org/unodc/en/data-and-analysis/world-drug-report-2025.html).
· extracted · link · source:references/10665-385385.sec-007.86.jsonWorld Drug Report 2025 [website]. United Nations Office on Drugs and Crime; 2025 (https://www.unodc.org/unodc/en/data-and-analysis/world-drug-report-2025.html).
- Issued
- 2025
- Type
- document
- As printed
- World Drug Report 2025 [website]. United Nations Office on Drugs and Crime; 2025 (https://www.unodc.org/unodc/en/data-and-analysis/world-drug-report-2025.html).
Sources
In the knowledge graph
- IRI
references/10665-385385.sec-007.86 - provenance: extracted
- read from
references/10665-385385.sec-007.86.json(who-iris, sub-graph who-iris-references) - derived from
library/10665-385385/sections/sec-007-references.md
-
Global status report on alcohol and health and treatment of substance use disorders. Geneva: World Health Organization; 2024 (https://iris.who.int/handle/10665/377960). Licence: CC BY-NC-SA 3.0 IGO.
· extracted · link · source:references/10665-385385.sec-007.87.jsonGlobal status report on alcohol and health and treatment of substance use disorders. Geneva: World Health Organization; 2024 (https://iris.who.int/handle/10665/377960). Licence: CC BY-NC-SA 3.0 IGO.
- Issued
- 2024
- Type
- document
- As printed
- Global status report on alcohol and health and treatment of substance use disorders. Geneva: World Health Organization; 2024 (https://iris.who.int/handle/10665/377960). Licence: CC BY-NC-SA 3.0 IGO.
Sources
- iris.who.int/handle/10665/377960 (canonical)
In the knowledge graph
- IRI
references/10665-385385.sec-007.87 - provenance: extracted
- read from
references/10665-385385.sec-007.87.json(who-iris, sub-graph who-iris-references) - derived from
library/10665-385385/sections/sec-007-references.md
-
Needle and syringe programmes for people who inject drugs: operational guide. Geneva: World Health Organization; 2025 (https://iris.who.int/handle/10665/384810). Licence: CC BY-NC-SA 3.0 IGO.
· extracted · link · source:references/10665-385385.sec-007.88.jsonNeedle and syringe programmes for people who inject drugs: operational guide. Geneva: World Health Organization; 2025 (https://iris.who.int/handle/10665/384810). Licence: CC BY-NC-SA 3.0 IGO.
- Issued
- 2025
- Type
- document
- As printed
- Needle and syringe programmes for people who inject drugs: operational guide. Geneva: World Health Organization; 2025 (https://iris.who.int/handle/10665/384810). Licence: CC BY-NC-SA 3.0 IGO.
Sources
- iris.who.int/handle/10665/384810 (canonical)
In the knowledge graph
- IRI
references/10665-385385.sec-007.88 - provenance: extracted
- read from
references/10665-385385.sec-007.88.json(who-iris, sub-graph who-iris-references) - derived from
library/10665-385385/sections/sec-007-references.md
-
Colledge-Frisby S, Ottaviano S, Webb P, Grebely J, Wheeler A, Cunningham EB et al. Global coverage of interventions to prevent and manage drug-related harms among people who inject drugs: a systematic review. The Lancet Global Health. 2023;11(5):e673-e83 (https://doi.org/10.1016/S2214-109X(23)00058-X).
· extracted · doi:10.1016/S2214-109X(23)00058-X · source:references/10665-385385.sec-007.89.jsonColledge-Frisby S, Ottaviano S, Webb P, Grebely J, Wheeler A, Cunningham EB et al. Global coverage of interventions to prevent and manage drug-related harms among people who inject drugs: a systematic review. The Lancet Global Health. 2023;11(5):e673-e83 (https://doi.org/10.1016/S2214-109X(23)00058-X).
- Issued
- 2023
- Type
- article-journal
- DOI
- 10.1016/S2214-109X(23)00058-X
- As printed
- Colledge-Frisby S, Ottaviano S, Webb P, Grebely J, Wheeler A, Cunningham EB et al. Global coverage of interventions to prevent and manage drug-related harms among people who inject drugs: a systematic review. The Lancet Global Health. 2023;11(5):e673-e83 (https://doi.org/10.1016/S2214-109X(23)00058-X).
Sources
In the knowledge graph
- IRI
references/10665-385385.sec-007.89 - provenance: extracted
- read from
references/10665-385385.sec-007.89.json(who-iris, sub-graph who-iris-references) - derived from
library/10665-385385/sections/sec-007-references.md
-
Global AIDS monitoring, 2024 [website]. UNAIDS; 2024 (https://www.unaids.org/en/global-aids-monitoring).
· extracted · link · source:references/10665-385385.sec-007.90.jsonGlobal AIDS monitoring, 2024 [website]. UNAIDS; 2024 (https://www.unaids.org/en/global-aids-monitoring).
- Issued
- 2024
- Type
- document
- As printed
- Global AIDS monitoring, 2024 [website]. UNAIDS; 2024 (https://www.unaids.org/en/global-aids-monitoring).
Sources
- www.unaids.org/en/global-aids-monitoring (canonical)
In the knowledge graph
- IRI
references/10665-385385.sec-007.90 - provenance: extracted
- read from
references/10665-385385.sec-007.90.json(who-iris, sub-graph who-iris-references) - derived from
library/10665-385385/sections/sec-007-references.md
-
Unitaid investments in hepatitis C – portfolio evaluation and end‑of‑grant evaluations of the FIND HEAD‑Start and Coalition PLUS grants. Geneva: Unitaid; 2021 (https://unitaid.org/uploads/Final_Report_HCVEvaluation_CEPA-1-1.pdf).| 75
· extracted · link · source:references/10665-385385.sec-007.91.jsonUnitaid investments in hepatitis C – portfolio evaluation and end‑of‑grant evaluations of the FIND HEAD‑Start and Coalition PLUS grants. Geneva: Unitaid; 2021 (https://unitaid.org/uploads/Final_Report_HCVEvaluation_CEPA-1-1.pdf).| 75
- Issued
- 2021
- Type
- document
- As printed
- Unitaid investments in hepatitis C – portfolio evaluation and end‑of‑grant evaluations of the FIND HEAD‑Start and Coalition PLUS grants. Geneva: Unitaid; 2021 (https://unitaid.org/uploads/Final_Report_HCVEvaluation_CEPA-1-1.pdf).| 75
Sources
In the knowledge graph
- IRI
references/10665-385385.sec-007.91 - provenance: extracted
- read from
references/10665-385385.sec-007.91.json(who-iris, sub-graph who-iris-references) - derived from
library/10665-385385/sections/sec-007-references.md
-
Unitaid landscape report: eliminating vertical transmission of HIV, hepatitis B, syphilis, and Chagas disease [website]. Unitaid; 2026 (https://unitaid.org/project/eliminating-vertical-transmission-of-hiv-hepatitis-b-syphilis-and-chagas-disease/).
· extracted · link · source:references/10665-385385.sec-007.92.jsonUnitaid landscape report: eliminating vertical transmission of HIV, hepatitis B, syphilis, and Chagas disease [website]. Unitaid; 2026 (https://unitaid.org/project/eliminating-vertical-transmission-of-hiv-hepatitis-b-syphilis-and-chagas-disease/).
- Issued
- 2026
- Type
- document
- As printed
- Unitaid landscape report: eliminating vertical transmission of HIV, hepatitis B, syphilis, and Chagas disease [website]. Unitaid; 2026 (https://unitaid.org/project/eliminating-vertical-transmission-of-hiv-hepatitis-b-syphilis-and-chagas-disease/).
Sources
- unitaid.org/project/eliminating-vertical-transmission-of-hiv-hepatitis-b-syphilis-and-chagas-disease/ (canonical)
In the knowledge graph
- IRI
references/10665-385385.sec-007.92 - provenance: extracted
- read from
references/10665-385385.sec-007.92.json(who-iris, sub-graph who-iris-references) - derived from
library/10665-385385/sections/sec-007-references.md
-
Painel de Monitoramento de Hepatites B e C [website]. Ministério da Saúde Secretaria de Vigilância em Saúde e Ambiente, Departamento de HIV Aids, Tuberculose Hepatites Virais e IST; (https://www.gov.br/aids/pt-br/indicadores-epidemiologicos/painel-de-monitoramento-de-hepatites-b-e-c).
· extracted · link · source:references/10665-385385.sec-007.93.jsonPainel de Monitoramento de Hepatites B e C [website]. Ministério da Saúde Secretaria de Vigilância em Saúde e Ambiente, Departamento de HIV Aids, Tuberculose Hepatites Virais e IST; (https://www.gov.br/aids/pt-br/indicadores-epidemiologicos/painel-de-monitoramento-de-hepatites-b-e-c).
- Type
- document
- As printed
- Painel de Monitoramento de Hepatites B e C [website]. Ministério da Saúde Secretaria de Vigilância em Saúde e Ambiente, Departamento de HIV Aids, Tuberculose Hepatites Virais e IST; (https://www.gov.br/aids/pt-br/indicadores-epidemiologicos/painel-de-monitoramento-de-hepatites-b-e-c).
Sources
- www.gov.br/aids/pt-br/indicadores-epidemiologicos/painel-de-monitoramento-de-hepatites-b-e-c (canonical)
In the knowledge graph
- IRI
references/10665-385385.sec-007.93 - provenance: extracted
- read from
references/10665-385385.sec-007.93.json(who-iris, sub-graph who-iris-references) - derived from
library/10665-385385/sections/sec-007-references.md
-
Nota Técnica nº 11/2025 – CGIST/DATHI/SVSA/MS. Brasília, Brazil: Ministério da Saúde Secretaria de Vigilância em Saúde e Ambiente, Departamento de HIV Aids, Tuberculose Hepatites Virais e IST; 2025 (https://www.gov.br/aids/pt-br/central-de-conteudo/notas-tecnicas/2025/nota-tecnica_no-11_2025_cgist_dathi_svsa_ms.pdf).
· extracted · link · source:references/10665-385385.sec-007.94.jsonNota Técnica nº 11/2025 – CGIST/DATHI/SVSA/MS. Brasília, Brazil: Ministério da Saúde Secretaria de Vigilância em Saúde e Ambiente, Departamento de HIV Aids, Tuberculose Hepatites Virais e IST; 2025 (https://www.gov.br/aids/pt-br/central-de-conteudo/notas-tecnicas/2025/nota-tecnica_no-11_2025_cgist_dathi_svsa_ms.pdf).
- Issued
- 2025
- Type
- document
- As printed
- Nota Técnica nº 11/2025 – CGIST/DATHI/SVSA/MS. Brasília, Brazil: Ministério da Saúde Secretaria de Vigilância em Saúde e Ambiente, Departamento de HIV Aids, Tuberculose Hepatites Virais e IST; 2025 (https://www.gov.br/aids/pt-br/central-de-conteudo/notas-tecnicas/2025/nota-tecnica_no-11_2025_cgist_dathi_svsa_ms.pdf).
Sources
In the knowledge graph
- IRI
references/10665-385385.sec-007.94 - provenance: extracted
- read from
references/10665-385385.sec-007.94.json(who-iris, sub-graph who-iris-references) - derived from
library/10665-385385/sections/sec-007-references.md
-
Guia para a Eliminação das Hepatites Virais no Brasil. Brasília, Brazil: Ministério da Saúde, Secretaria de Vigilância em Saúde e Ambiente, Departamento de HIV, Aids, Tuberculose, Hepatites Virais e IST; 2025 (https://bvsms.saude.gov.br/bvs/publicacoes/guia_eliminacao_hepatites_virais_Brasil.pdf).
· extracted · link · source:references/10665-385385.sec-007.95.jsonGuia para a Eliminação das Hepatites Virais no Brasil. Brasília, Brazil: Ministério da Saúde, Secretaria de Vigilância em Saúde e Ambiente, Departamento de HIV, Aids, Tuberculose, Hepatites Virais e IST; 2025 (https://bvsms.saude.gov.br/bvs/publicacoes/guia_eliminacao_hepatites_virais_Brasil.pdf).
- Issued
- 2025
- Type
- document
- As printed
- Guia para a Eliminação das Hepatites Virais no Brasil. Brasília, Brazil: Ministério da Saúde, Secretaria de Vigilância em Saúde e Ambiente, Departamento de HIV, Aids, Tuberculose, Hepatites Virais e IST; 2025 (https://bvsms.saude.gov.br/bvs/publicacoes/guia_eliminacao_hepatites_virais_Brasil.pdf).
Sources
In the knowledge graph
- IRI
references/10665-385385.sec-007.95 - provenance: extracted
- read from
references/10665-385385.sec-007.95.json(who-iris, sub-graph who-iris-references) - derived from
library/10665-385385/sections/sec-007-references.md
-
Boletim Epidemiológico – Hepatites Virais 2025. Brasília, Brazil: Ministério da Saúde, Secretaria de Vigilância em Saúde e Ambiente, Departamento de HIV, Aids, Tuberculose, Hepatites Virais e IST; 2025 (https://www.gov.br/saude/pt-br/centrais-de-conteudo/publicacoes/boletins/epidemiologicos/especiais/2025/boletim-epidemiologico-de-hepatites-virais.pdf).
· extracted · link · source:references/10665-385385.sec-007.96.jsonBoletim Epidemiológico – Hepatites Virais 2025. Brasília, Brazil: Ministério da Saúde, Secretaria de Vigilância em Saúde e Ambiente, Departamento de HIV, Aids, Tuberculose, Hepatites Virais e IST; 2025 (https://www.gov.br/saude/pt-br/centrais-de-conteudo/publicacoes/boletins/epidemiologicos/especiais/2025/boletim-epidemiologico-de-hepatites-virais.pdf).
- Issued
- 2025
- Type
- document
- As printed
- Boletim Epidemiológico – Hepatites Virais 2025. Brasília, Brazil: Ministério da Saúde, Secretaria de Vigilância em Saúde e Ambiente, Departamento de HIV, Aids, Tuberculose, Hepatites Virais e IST; 2025 (https://www.gov.br/saude/pt-br/centrais-de-conteudo/publicacoes/boletins/epidemiologicos/especiais/2025/boletim-epidemiologico-de-hepatites-virais.pdf).
Sources
In the knowledge graph
- IRI
references/10665-385385.sec-007.96 - provenance: extracted
- read from
references/10665-385385.sec-007.96.json(who-iris, sub-graph who-iris-references) - derived from
library/10665-385385/sections/sec-007-references.md
-
Gomaa A, Gomaa M, Allam N, Waked I. Hepatitis C elimination in Egypt: story of success. Pathogens. 2024;13(8):681 (https://doi.org/10.3390/pathogens13080681).
· extracted · doi:10.3390/pathogens13080681 · source:references/10665-385385.sec-007.97.jsonGomaa A, Gomaa M, Allam N, Waked I. Hepatitis C elimination in Egypt: story of success. Pathogens. 2024;13(8):681 (https://doi.org/10.3390/pathogens13080681).
- Issued
- 2024
- Type
- article-journal
- DOI
- 10.3390/pathogens13080681
- As printed
- Gomaa A, Gomaa M, Allam N, Waked I. Hepatitis C elimination in Egypt: story of success. Pathogens. 2024;13(8):681 (https://doi.org/10.3390/pathogens13080681).
Sources
In the knowledge graph
- IRI
references/10665-385385.sec-007.97 - provenance: extracted
- read from
references/10665-385385.sec-007.97.json(who-iris, sub-graph who-iris-references) - derived from
library/10665-385385/sections/sec-007-references.md
-
Ezzat S, Gamkrelidze I, Osman A, Gomaa A, Roushdy A, Esmat G et al. Impacts of the Egyptian national screening and treatment programme for viral hepatitis C: a cost-effectiveness model. Liver Int. 2023;43(7):1417-26 (https://doi.org/10.1111/liv.15584).
· extracted · doi:10.1111/liv.15584 · source:references/10665-385385.sec-007.98.jsonEzzat S, Gamkrelidze I, Osman A, Gomaa A, Roushdy A, Esmat G et al. Impacts of the Egyptian national screening and treatment programme for viral hepatitis C: a cost-effectiveness model. Liver Int. 2023;43(7):1417-26 (https://doi.org/10.1111/liv.15584).
- Issued
- 2023
- Type
- article-journal
- DOI
- 10.1111/liv.15584
- As printed
- Ezzat S, Gamkrelidze I, Osman A, Gomaa A, Roushdy A, Esmat G et al. Impacts of the Egyptian national screening and treatment programme for viral hepatitis C: a cost-effectiveness model. Liver Int. 2023;43(7):1417-26 (https://doi.org/10.1111/liv.15584).
Sources
- doi:10.1111/liv.15584 (doi)
In the knowledge graph
- IRI
references/10665-385385.sec-007.98 - provenance: extracted
- read from
references/10665-385385.sec-007.98.json(who-iris, sub-graph who-iris-references) - derived from
library/10665-385385/sections/sec-007-references.md
-
Egypt’s viral hepatitis program – burden and response: an economic analysis. Washington D.C., U.S.A.: World Bank; 2017 (https://documents1.worldbank.org/curated/en/972381517328583384/pdf/123066-WP-PUBLIC-P157533-Burden-and-response-An-Economic-Analysis.pdf).
· extracted · link · source:references/10665-385385.sec-007.99.jsonEgypt’s viral hepatitis program – burden and response: an economic analysis. Washington D.C., U.S.A.: World Bank; 2017 (https://documents1.worldbank.org/curated/en/972381517328583384/pdf/123066-WP-PUBLIC-P157533-Burden-and-response-An-Economic-Analysis.pdf).
- Issued
- 2017
- Type
- document
- As printed
- Egypt’s viral hepatitis program – burden and response: an economic analysis. Washington D.C., U.S.A.: World Bank; 2017 (https://documents1.worldbank.org/curated/en/972381517328583384/pdf/123066-WP-PUBLIC-P157533-Burden-and-response-An-Economic-Analysis.pdf).
Sources
In the knowledge graph
- IRI
references/10665-385385.sec-007.99 - provenance: extracted
- read from
references/10665-385385.sec-007.99.json(who-iris, sub-graph who-iris-references) - derived from
library/10665-385385/sections/sec-007-references.md
-
Salomon I, Olivier S, Egide N. Advancing hepatitis C elimination in Africa: insights from Egypt. Hepatic Med. 2024:37-44 (https://doi.org/10.2147/HMER.S470344).
· extracted · doi:10.2147/HMER.S470344 · source:references/10665-385385.sec-007.100.jsonSalomon I, Olivier S, Egide N. Advancing hepatitis C elimination in Africa: insights from Egypt. Hepatic Med. 2024:37-44 (https://doi.org/10.2147/HMER.S470344).
- Issued
- 2024
- Type
- document
- DOI
- 10.2147/HMER.S470344
- As printed
- Salomon I, Olivier S, Egide N. Advancing hepatitis C elimination in Africa: insights from Egypt. Hepatic Med. 2024:37-44 (https://doi.org/10.2147/HMER.S470344).
Sources
- doi:10.2147/HMER.S470344 (doi)
In the knowledge graph
- IRI
references/10665-385385.sec-007.100 - provenance: extracted
- read from
references/10665-385385.sec-007.100.json(who-iris, sub-graph who-iris-references) - derived from
library/10665-385385/sections/sec-007-references.md
-
Qureshi H, Mahmood H, Saleem S, Aabroo A. Prime Minister’s hepatitis C elimination program in Pakistan. In: Elimination of Viral Hepatitis B and C–Global Initiatives, National Programs, and Scientific Advances: IntechOpen; 2025: (https://doi.org/10.5772/intechopen.115658).
· extracted · doi:10.5772/intechopen.115658 · source:references/10665-385385.sec-007.101.jsonQureshi H, Mahmood H, Saleem S, Aabroo A. Prime Minister’s hepatitis C elimination program in Pakistan. In: Elimination of Viral Hepatitis B and C–Global Initiatives, National Programs, and Scientific Advances: IntechOpen; 2025: (https://doi.org/10.5772/intechopen.115658).
- Issued
- 2025
- Type
- document
- DOI
- 10.5772/intechopen.115658
- As printed
- Qureshi H, Mahmood H, Saleem S, Aabroo A. Prime Minister’s hepatitis C elimination program in Pakistan. In: Elimination of Viral Hepatitis B and C–Global Initiatives, National Programs, and Scientific Advances: IntechOpen; 2025: (https://doi.org/10.5772/intechopen.115658).
Sources
In the knowledge graph
- IRI
references/10665-385385.sec-007.101 - provenance: extracted
- read from
references/10665-385385.sec-007.101.json(who-iris, sub-graph who-iris-references) - derived from
library/10665-385385/sections/sec-007-references.md
-
Lim AG, Scott N, Walker JG, Hamid S, Hellard M, Vickerman P. Health and economic benefits of achieving hepatitis C virus elimination in Pakistan: A modelling study and economic analysis. PLoS medicine. 2021;18(10):e1003818 (https://doi.org/10.1371/journal.pmed.1003818).
· extracted · doi:10.1371/journal.pmed.1003818 · source:references/10665-385385.sec-007.102.jsonLim AG, Scott N, Walker JG, Hamid S, Hellard M, Vickerman P. Health and economic benefits of achieving hepatitis C virus elimination in Pakistan: A modelling study and economic analysis. PLoS medicine. 2021;18(10):e1003818 (https://doi.org/10.1371/journal.pmed.1003818).
- Issued
- 2021
- Type
- article-journal
- DOI
- 10.1371/journal.pmed.1003818
- As printed
- Lim AG, Scott N, Walker JG, Hamid S, Hellard M, Vickerman P. Health and economic benefits of achieving hepatitis C virus elimination in Pakistan: A modelling study and economic analysis. PLoS medicine. 2021;18(10):e1003818 (https://doi.org/10.1371/journal.pmed.1003818).
Sources
In the knowledge graph
- IRI
references/10665-385385.sec-007.102 - provenance: extracted
- read from
references/10665-385385.sec-007.102.json(who-iris, sub-graph who-iris-references) - derived from
library/10665-385385/sections/sec-007-references.md
-
Selden O, Rusingiza E, Balkrishnan R. Overview, infrastructural challenges, barriers to access, and progress for Rwanda’s healthcare system: a review. Integrative Journal of Medical Sciences. 2025;12 (https://doi.org/10.15342/ijms.2025.745).
· extracted · doi:10.15342/ijms.2025.745 · source:references/10665-385385.sec-007.103.jsonSelden O, Rusingiza E, Balkrishnan R. Overview, infrastructural challenges, barriers to access, and progress for Rwanda’s healthcare system: a review. Integrative Journal of Medical Sciences. 2025;12 (https://doi.org/10.15342/ijms.2025.745).
- Issued
- 2025
- Type
- document
- DOI
- 10.15342/ijms.2025.745
- As printed
- Selden O, Rusingiza E, Balkrishnan R. Overview, infrastructural challenges, barriers to access, and progress for Rwanda’s healthcare system: a review. Integrative Journal of Medical Sciences. 2025;12 (https://doi.org/10.15342/ijms.2025.745).
Sources
In the knowledge graph
- IRI
references/10665-385385.sec-007.103 - provenance: extracted
- read from
references/10665-385385.sec-007.103.json(who-iris, sub-graph who-iris-references) - derived from
library/10665-385385/sections/sec-007-references.md
-
Zhong H, Aaron A, Hiebert L, Serumondo J, Zhuo Y, Adee M et al. Hepatitis C elimination in Rwanda: progress, feasibility, and economic evaluation. Value Health. 2024;27(7):918-25 (https://doi.org/10.1016/j.jval.2024.03.005).
· extracted · doi:10.1016/j.jval.2024.03.005 · source:references/10665-385385.sec-007.104.jsonZhong H, Aaron A, Hiebert L, Serumondo J, Zhuo Y, Adee M et al. Hepatitis C elimination in Rwanda: progress, feasibility, and economic evaluation. Value Health. 2024;27(7):918-25 (https://doi.org/10.1016/j.jval.2024.03.005).
- Issued
- 2024
- Type
- article-journal
- DOI
- 10.1016/j.jval.2024.03.005
- As printed
- Zhong H, Aaron A, Hiebert L, Serumondo J, Zhuo Y, Adee M et al. Hepatitis C elimination in Rwanda: progress, feasibility, and economic evaluation. Value Health. 2024;27(7):918-25 (https://doi.org/10.1016/j.jval.2024.03.005).
Sources
In the knowledge graph
- IRI
references/10665-385385.sec-007.104 - provenance: extracted
- read from
references/10665-385385.sec-007.104.json(who-iris, sub-graph who-iris-references) - derived from
library/10665-385385/sections/sec-007-references.md
-
Hepatitis C elimination: Rwanda on the last mile [website]. Ministry of Health Rwanda; 2022 (https://www.moh.gov.rw/news-detail/hepatitis-c-elimination-rwanda-on-the-last-mile).
· extracted · link · source:references/10665-385385.sec-007.105.jsonHepatitis C elimination: Rwanda on the last mile [website]. Ministry of Health Rwanda; 2022 (https://www.moh.gov.rw/news-detail/hepatitis-c-elimination-rwanda-on-the-last-mile).
- Issued
- 2022
- Type
- document
- As printed
- Hepatitis C elimination: Rwanda on the last mile [website]. Ministry of Health Rwanda; 2022 (https://www.moh.gov.rw/news-detail/hepatitis-c-elimination-rwanda-on-the-last-mile).
Sources
In the knowledge graph
- IRI
references/10665-385385.sec-007.105 - provenance: extracted
- read from
references/10665-385385.sec-007.105.json(who-iris, sub-graph who-iris-references) - derived from
library/10665-385385/sections/sec-007-references.md
-
The national digital health strategic plan, 2018–2023 [website]. Ministry of Health Rwanda; 2018 (https://extranet.who.int/countryplanningcycles/sites/default/files/public_file_rep/RWA_Rwanda_Digital-Health-Strategy_2018-2023.Pdf).
· extracted · link · source:references/10665-385385.sec-007.106.jsonThe national digital health strategic plan, 2018–2023 [website]. Ministry of Health Rwanda; 2018 (https://extranet.who.int/countryplanningcycles/sites/default/files/public_file_rep/RWA_Rwanda_Digital-Health-Strategy_2018-2023.Pdf).
- Issued
- 2018
- Type
- document
- As printed
- The national digital health strategic plan, 2018–2023 [website]. Ministry of Health Rwanda; 2018 (https://extranet.who.int/countryplanningcycles/sites/default/files/public_file_rep/RWA_Rwanda_Digital-Health-Strategy_2018-2023.Pdf).
Sources
In the knowledge graph
- IRI
references/10665-385385.sec-007.106 - provenance: extracted
- read from
references/10665-385385.sec-007.106.json(who-iris, sub-graph who-iris-references) - derived from
library/10665-385385/sections/sec-007-references.md
-
Kanokudom S, Nilyanimit P, Puenpa J, Suntronwong N, Le DHH, Wongsrisang L et al. A comparative national survey on the gradual decline of hepatitis C virus prevalence in Thailand, 2004, 2014, and 2024. Sci Rep. 2025;15(1):19794 (https://doi.org/10.1038/s41598-025-04578-0).
· extracted · doi:10.1038/s41598-025-04578-0 · source:references/10665-385385.sec-007.107.jsonKanokudom S, Nilyanimit P, Puenpa J, Suntronwong N, Le DHH, Wongsrisang L et al. A comparative national survey on the gradual decline of hepatitis C virus prevalence in Thailand, 2004, 2014, and 2024. Sci Rep. 2025;15(1):19794 (https://doi.org/10.1038/s41598-025-04578-0).
- Issued
- 2025
- Type
- article-journal
- DOI
- 10.1038/s41598-025-04578-0
- As printed
- Kanokudom S, Nilyanimit P, Puenpa J, Suntronwong N, Le DHH, Wongsrisang L et al. A comparative national survey on the gradual decline of hepatitis C virus prevalence in Thailand, 2004, 2014, and 2024. Sci Rep. 2025;15(1):19794 (https://doi.org/10.1038/s41598-025-04578-0).
Sources
In the knowledge graph
- IRI
references/10665-385385.sec-007.107 - provenance: extracted
- read from
references/10665-385385.sec-007.107.json(who-iris, sub-graph who-iris-references) - derived from
library/10665-385385/sections/sec-007-references.md
-
Tangcharoensathien V, Witthayapipopsakul W, Panichkriangkrai W, Patcharanarumol W, Mills A. Health systems development in Thailand: a solid platform for successful implementation of universal health coverage. Lancet. 2018;391(10126):1205-23 (https://doi.org/10.1016/S0140-6736(18)30198-3).
· extracted · doi:10.1016/S0140-6736(18)30198-3 · source:references/10665-385385.sec-007.108.jsonTangcharoensathien V, Witthayapipopsakul W, Panichkriangkrai W, Patcharanarumol W, Mills A. Health systems development in Thailand: a solid platform for successful implementation of universal health coverage. Lancet. 2018;391(10126):1205-23 (https://doi.org/10.1016/S0140-6736(18)30198-3).
- Issued
- 2018
- Type
- article-journal
- DOI
- 10.1016/S0140-6736(18)30198-3
- As printed
- Tangcharoensathien V, Witthayapipopsakul W, Panichkriangkrai W, Patcharanarumol W, Mills A. Health systems development in Thailand: a solid platform for successful implementation of universal health coverage. Lancet. 2018;391(10126):1205-23 (https://doi.org/10.1016/S0140-6736(18)30198-3).
Sources
In the knowledge graph
- IRI
references/10665-385385.sec-007.108 - provenance: extracted
- read from
references/10665-385385.sec-007.108.json(who-iris, sub-graph who-iris-references) - derived from
library/10665-385385/sections/sec-007-references.md
-
Degenhardt L, Webb P, Colledge-Frisby S, Ireland J, Wheeler A, Ottaviano S et al. Epidemiology of injecting drug use, prevalence of injecting-related harm, and exposure to behavioural and environmental risks among people who inject drugs: a systematic review. Lancet Glob Health. 2023;11(5):e659-e72 (https://doi.org/10.1016/S2214-109X(23)00057-8. PMICD:PMC12580156). The following references were accessed on 23 April 2026: 7, 8,12, 18, 56, 77, 81, 83, 86, 90–96, 105 and 106.
· extracted · doi:10.1016/S2214-109X(23)00057-8 · source:references/10665-385385.sec-007.109.jsonDegenhardt L, Webb P, Colledge-Frisby S, Ireland J, Wheeler A, Ottaviano S et al. Epidemiology of injecting drug use, prevalence of injecting-related harm, and exposure to behavioural and environmental risks among people who inject drugs: a systematic review. Lancet Glob Health. 2023;11(5):e659-e72 (https://doi.org/10.1016/S2214-109X(23)00057-8. PMICD:PMC12580156). The following references were accessed on 23 April 2026: 7, 8,12, 18, 56, 77, 81, 83, 86, 90–96, 105 and 106.
- Issued
- 2023
- Type
- article-journal
- DOI
- 10.1016/S2214-109X(23)00057-8
- Accessed
- on 23 April 2026
- As printed
- Degenhardt L, Webb P, Colledge-Frisby S, Ireland J, Wheeler A, Ottaviano S et al. Epidemiology of injecting drug use, prevalence of injecting-related harm, and exposure to behavioural and environmental risks among people who inject drugs: a systematic review. Lancet Glob Health. 2023;11(5):e659-e72 (https://doi.org/10.1016/S2214-109X(23)00057-8. PMICD:PMC12580156). The following references were accessed on 23 April 2026: 7, 8,12, 18, 56, 77, 81, 83, 86, 90–96, 105 and 106.
Sources
In the knowledge graph
- IRI
references/10665-385385.sec-007.109 - provenance: extracted
- read from
references/10665-385385.sec-007.109.json(who-iris, sub-graph who-iris-references) - derived from
library/10665-385385/sections/sec-007-references.md
-
Global hepatitis report 2017. Geneva: World Health Organization; 2017 (https://iris.who.int/handle/10665/255016). Licence: CC BY-NC-SA 3.0 IGO.
· extracted · link · source:references/10665-385385.sec-008.1.jsonGlobal hepatitis report 2017. Geneva: World Health Organization; 2017 (https://iris.who.int/handle/10665/255016). Licence: CC BY-NC-SA 3.0 IGO.
- Issued
- 2017
- Type
- document
- As printed
- Global hepatitis report 2017. Geneva: World Health Organization; 2017 (https://iris.who.int/handle/10665/255016). Licence: CC BY-NC-SA 3.0 IGO.
Sources
- iris.who.int/handle/10665/255016 (canonical)
In the knowledge graph
- IRI
references/10665-385385.sec-008.1 - provenance: extracted
- read from
references/10665-385385.sec-008.1.json(who-iris, sub-graph who-iris-references) - derived from
library/10665-385385/sections/sec-008-annex-1-methodological-notes.md
-
Global hepatitis report 2024: action for access in low- and middle-income countries. Geneva: World Health Organization; 2024 (https://iris.who.int/handle/10665/376461). Licence: CC BY-NC-SA 3.0 IGO.
· extracted · link · source:references/10665-385385.sec-008.2.jsonGlobal hepatitis report 2024: action for access in low- and middle-income countries. Geneva: World Health Organization; 2024 (https://iris.who.int/handle/10665/376461). Licence: CC BY-NC-SA 3.0 IGO.
- Issued
- 2024
- Type
- document
- As printed
- Global hepatitis report 2024: action for access in low- and middle-income countries. Geneva: World Health Organization; 2024 (https://iris.who.int/handle/10665/376461). Licence: CC BY-NC-SA 3.0 IGO.
Sources
- iris.who.int/handle/10665/376461 (canonical)
In the knowledge graph
- IRI
references/10665-385385.sec-008.2 - provenance: extracted
- read from
references/10665-385385.sec-008.2.json(who-iris, sub-graph who-iris-references) - derived from
library/10665-385385/sections/sec-008-annex-1-methodological-notes.md
-
Global health sector strategy on viral hepatitis 2016–2021. Towards ending viral hepatitis. Geneva: World Health Organization; 2016 (https://iris.who.int/handle/10665/246177).
· extracted · link · source:references/10665-385385.sec-008.3.jsonGlobal health sector strategy on viral hepatitis 2016–2021. Towards ending viral hepatitis. Geneva: World Health Organization; 2016 (https://iris.who.int/handle/10665/246177).
- Issued
- 2016
- Type
- document
- As printed
- Global health sector strategy on viral hepatitis 2016–2021. Towards ending viral hepatitis. Geneva: World Health Organization; 2016 (https://iris.who.int/handle/10665/246177).
Sources
- iris.who.int/handle/10665/246177 (canonical)
In the knowledge graph
- IRI
references/10665-385385.sec-008.3 - provenance: extracted
- read from
references/10665-385385.sec-008.3.json(who-iris, sub-graph who-iris-references) - derived from
library/10665-385385/sections/sec-008-annex-1-methodological-notes.md
-
Global health sector strategies on, respectively, HIV, viral hepatitis and sexually transmitted infections for the period 2022–2030. Geneva: World Health Organization; 2022 (https://iris.who.int/handle/10665/360348).Licence: CC BY-NC-SA 3.0 IGO.
· extracted · link · source:references/10665-385385.sec-008.4.jsonGlobal health sector strategies on, respectively, HIV, viral hepatitis and sexually transmitted infections for the period 2022–2030. Geneva: World Health Organization; 2022 (https://iris.who.int/handle/10665/360348).Licence: CC BY-NC-SA 3.0 IGO.
- Issued
- 2022
- Type
- document
- As printed
- Global health sector strategies on, respectively, HIV, viral hepatitis and sexually transmitted infections for the period 2022–2030. Geneva: World Health Organization; 2022 (https://iris.who.int/handle/10665/360348).Licence: CC BY-NC-SA 3.0 IGO.
Sources
- iris.who.int/handle/10665/360348).Licence: (canonical)
In the knowledge graph
- IRI
references/10665-385385.sec-008.4 - provenance: extracted
- read from
references/10665-385385.sec-008.4.json(who-iris, sub-graph who-iris-references) - derived from
library/10665-385385/sections/sec-008-annex-1-methodological-notes.md
-
Viral hepatitis country profiles [website]. World Health Organization; 2025 (https://data.who.int/dashboards/hepatitis/epidemiology).
· extracted · link · source:references/10665-385385.sec-008.5.jsonViral hepatitis country profiles [website]. World Health Organization; 2025 (https://data.who.int/dashboards/hepatitis/epidemiology).
- Issued
- 2025
- Type
- document
- As printed
- Viral hepatitis country profiles [website]. World Health Organization; 2025 (https://data.who.int/dashboards/hepatitis/epidemiology).
Sources
- data.who.int/dashboards/hepatitis/epidemiology (canonical)
In the knowledge graph
- IRI
references/10665-385385.sec-008.5 - provenance: extracted
- read from
references/10665-385385.sec-008.5.json(who-iris, sub-graph who-iris-references) - derived from
library/10665-385385/sections/sec-008-annex-1-methodological-notes.md
-
Guidance for country validation of viral hepatitis elimination and path to elimination: technical report. Geneva: World Health Organization; 2023 (https://iris.who.int/handle/10665/373186). Licence: CC BY-NC-SA 3.0 IGO.
· extracted · link · source:references/10665-385385.sec-008.6.jsonGuidance for country validation of viral hepatitis elimination and path to elimination: technical report. Geneva: World Health Organization; 2023 (https://iris.who.int/handle/10665/373186). Licence: CC BY-NC-SA 3.0 IGO.
- Issued
- 2023
- Type
- document
- As printed
- Guidance for country validation of viral hepatitis elimination and path to elimination: technical report. Geneva: World Health Organization; 2023 (https://iris.who.int/handle/10665/373186). Licence: CC BY-NC-SA 3.0 IGO.
Sources
- iris.who.int/handle/10665/373186 (canonical)
In the knowledge graph
- IRI
references/10665-385385.sec-008.6 - provenance: extracted
- read from
references/10665-385385.sec-008.6.json(who-iris, sub-graph who-iris-references) - derived from
library/10665-385385/sections/sec-008-annex-1-methodological-notes.md
-
Guidelines for the prevention, diagnosis, care and treatment for people with chronic hepatitis B infection. Geneva: World Health Organization; 2024 (https://iris.who.int/handle/10665/376353). Licence: CC BY-NC-SA 3.0
· extracted · link · source:references/10665-385385.sec-008.7.jsonGuidelines for the prevention, diagnosis, care and treatment for people with chronic hepatitis B infection. Geneva: World Health Organization; 2024 (https://iris.who.int/handle/10665/376353). Licence: CC BY-NC-SA 3.0
- Issued
- 2024
- Type
- document
- As printed
- Guidelines for the prevention, diagnosis, care and treatment for people with chronic hepatitis B infection. Geneva: World Health Organization; 2024 (https://iris.who.int/handle/10665/376353). Licence: CC BY-NC-SA 3.0
Sources
- iris.who.int/handle/10665/376353 (canonical)
In the knowledge graph
- IRI
references/10665-385385.sec-008.7 - provenance: extracted
- read from
references/10665-385385.sec-008.7.json(who-iris, sub-graph who-iris-references) - derived from
library/10665-385385/sections/sec-008-annex-1-methodological-notes.md
-
Global health sector strategies on, respectively, HIV, viral hepatitis and sexually transmitted infections for the period 2022–2030. Geneva: World Health Organization; 2022 (https://iris.who.int/handle/10665/360348).Licence: CC BY-NC-SA 3.0 IGO.
· extracted · link · source:references/10665-385385.sec-009.1.jsonGlobal health sector strategies on, respectively, HIV, viral hepatitis and sexually transmitted infections for the period 2022–2030. Geneva: World Health Organization; 2022 (https://iris.who.int/handle/10665/360348).Licence: CC BY-NC-SA 3.0 IGO.
- Issued
- 2022
- Type
- document
- As printed
- Global health sector strategies on, respectively, HIV, viral hepatitis and sexually transmitted infections for the period 2022–2030. Geneva: World Health Organization; 2022 (https://iris.who.int/handle/10665/360348).Licence: CC BY-NC-SA 3.0 IGO.
Sources
- iris.who.int/handle/10665/360348).Licence: (canonical)
In the knowledge graph
- IRI
references/10665-385385.sec-009.1 - provenance: extracted
- read from
references/10665-385385.sec-009.1.json(who-iris, sub-graph who-iris-references) - derived from
library/10665-385385/sections/sec-009-annex-2-the-global-hepatitis-reporting-process.md
-
Global reporting on HIV, hepatitis, and STIs [website]. World Health Organization; 2026 (https://www.who.int/teams/global-hiv-hepatitis-and-stis-programmes/strategies/global-health-sector-strategies/global-reporting-on-hiv-hepatitis-and-stis).
· extracted · link · source:references/10665-385385.sec-009.2.jsonGlobal reporting on HIV, hepatitis, and STIs [website]. World Health Organization; 2026 (https://www.who.int/teams/global-hiv-hepatitis-and-stis-programmes/strategies/global-health-sector-strategies/global-reporting-on-hiv-hepatitis-and-stis).
- Issued
- 2026
- Type
- document
- As printed
- Global reporting on HIV, hepatitis, and STIs [website]. World Health Organization; 2026 (https://www.who.int/teams/global-hiv-hepatitis-and-stis-programmes/strategies/global-health-sector-strategies/global-reporting-on-hiv-hepatitis-and-stis).
Sources
In the knowledge graph
- IRI
references/10665-385385.sec-009.2 - provenance: extracted
- read from
references/10665-385385.sec-009.2.json(who-iris, sub-graph who-iris-references) - derived from
library/10665-385385/sections/sec-009-annex-2-the-global-hepatitis-reporting-process.md
-
Resolution WHA63.18. Viral hepatitis. In: Sixty-third World Health Assembly, Geneva, 17–21 May 2010. Resolutions and decisions, annexes. Geneva: World Health Organization; 2010 (http://apps.who.int/gb/ebwha/pdf_files/WHA63-REC1/WHA63_REC1-en.pdf).
· extracted · link · source:references/10665-385385.sec-010.1.jsonResolution WHA63.18. Viral hepatitis. In: Sixty-third World Health Assembly, Geneva, 17–21 May 2010. Resolutions and decisions, annexes. Geneva: World Health Organization; 2010 (http://apps.who.int/gb/ebwha/pdf_files/WHA63-REC1/WHA63_REC1-en.pdf).
- Issued
- 2010
- Type
- document
- As printed
- Resolution WHA63.18. Viral hepatitis. In: Sixty-third World Health Assembly, Geneva, 17–21 May 2010. Resolutions and decisions, annexes. Geneva: World Health Organization; 2010 (http://apps.who.int/gb/ebwha/pdf_files/WHA63-REC1/WHA63_REC1-en.pdf).
Sources
In the knowledge graph
- IRI
references/10665-385385.sec-010.1 - provenance: extracted
- read from
references/10665-385385.sec-010.1.json(who-iris, sub-graph who-iris-references) - derived from
library/10665-385385/sections/sec-010-annex-3-world-health-assembly-resolutions-on-vir.md
-
Resolution WHA67.6. Hepatitis. In: Sixty-seventh World Health Assembly, Geneva, 19–24 May 2014. Resolutions and decisions, annexes. Geneva: World Health Organization; 2014 (http://apps.who.int/gb/ebwha/pdf_files/WHA67/A67_R6-en.pdf).Box A3.2. The second World Health Assembly resolution on viral hepatitis in 2014 (WHA67.6): summary of Member State commitments and requests to WHO (2) f National strategies. Develop and implement coordinated multisectoral strategies for prevention, diagnosis and treatment, based on local epidemiology. f Health promotion and immunization. Strengthen health promotion and prevention, and enhance immunization strategies, including for hepatitis A, and for hepatitis B through a timely birth dose.
· extracted · link · source:references/10665-385385.sec-010.2.jsonResolution WHA67.6. Hepatitis. In: Sixty-seventh World Health Assembly, Geneva, 19–24 May 2014. Resolutions and decisions, annexes. Geneva: World Health Organization; 2014 (http://apps.who.int/gb/ebwha/pdf_files/WHA67/A67_R6-en.pdf).Box A3.2. The second World Health Assembly resolution on viral hepatitis in 2014 (WHA67.6): summary of Member State commitments and requests to WHO (2) f National strategies. Develop and implement coordinated multisectoral strategies for prevention, diagnosis and treatment, based on local epidemiology. f Health promotion and immunization. Strengthen health promotion and prevention, and enhance immunization strategies, including for hepatitis A, and for hepatitis B through a timely birth dose.
- Issued
- 2014
- Type
- document
- As printed
- Resolution WHA67.6. Hepatitis. In: Sixty-seventh World Health Assembly, Geneva, 19–24 May 2014. Resolutions and decisions, annexes. Geneva: World Health Organization; 2014 (http://apps.who.int/gb/ebwha/pdf_files/WHA67/A67_R6-en.pdf).Box A3.2. The second World Health Assembly resolution on viral hepatitis in 2014 (WHA67.6): summary of Member State commitments and requests to WHO (2) f National strategies. Develop and implement coordinated multisectoral strategies for prevention, diagnosis and treatment, based on local epidemiology. f Health promotion and immunization. Strengthen health promotion and prevention, and enhance immunization strategies, including for hepatitis A, and for hepatitis B through a timely birth dose.
Sources
In the knowledge graph
- IRI
references/10665-385385.sec-010.2 - provenance: extracted
- read from
references/10665-385385.sec-010.2.json(who-iris, sub-graph who-iris-references) - derived from
library/10665-385385/sections/sec-010-annex-3-world-health-assembly-resolutions-on-vir.md